###### Strengths and limitations of this study

-   This is the first systematic review on the epidemiology of medication errors and medication-associated harm in community settings. The use of the International Classification for Patient Safety conceptual framework helped with framing and organising the findings from this systematic review.

-   A rigorous and transparent process has been employed, which included no language restrictions in undertaking searches, independent screening of titles, abstracts and full-text papers, independent data extraction, and critical appraisal of included studies by two reviewers.
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-   Outcomes have been reported in a variety of ways using different tools and methodology, which made it difficult to undertake any quantitative pooled summary of the results.

-   Despite the comprehensiveness of the searches, we found no data regarding errors during medication dispensing and administration. This might be due to the lack of 'dispensing error' and 'administration error' terms in our search strategy, although 'medication therapy management' was included as a more overarching search term.

-   There is at present no agreed, consistently applied set of confounders that should be taken into account when trying to make causal inferences.

Introduction {#s1}
============

Patient safety is a public concern in healthcare systems across the world.[@R1] Medication errors and error-related adverse drug events (ADEs) are common and are responsible for considerable patient harm.[@R1] More specifically, ADEs can lead to morbidity, hospitalisation, increased healthcare costs and, in some cases, death.[@R1] It has been estimated that 5%--6% of all hospitalisations are drug-related,[@R2] with one estimate suggesting that ADEs causing hospital admission in the UK occur in around 10% of inpatients; approximately half of these ADEs are believed to be preventable.[@R4] The cost of medication errors worldwide has been estimated as US\$42 billion/year.[@R5]

Since the release of *To Err is Human: Building a Safer Health System* by the Institute of Medicine (now the National Academy of Medicine),[@R6] which focused on acute care settings, most patient safety research has been conducted in hospital settings.[@R7] Given that international and national policy drivers are for patients to be increasingly managed in primary, ambulatory and home settings in order to realise the goals of more accessible, patient-centred and efficient healthcare,[@R9] there is an increased sense of urgency to further focus attention on community care contexts, particularly in relation to medication safety. With an ageing population, particularly in economically developed countries, as well as the use of polypharmacy, there is a need to empower patients, particularly those with chronic diseases, to self-care safely.

The aim of this systematic review was to investigate the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts (ie, primary care, ambulatory and home settings). [Box 1](#B1){ref-type="boxed-text"} provides definitions of the key terms employed in this review.Box 1Key definitionsAdverse drug event (ADE): Bates *et al* [@R84] define ADE as *'an injury resulting from medical intervention related to a drug'*. [@R84] Some ADEs are caused by underlying medication errors and therefore they are preventable.Medication error: The National Coordinating Council for Medication Error Reporting and Prevention defines a medication error as *'any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labelling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use'*. [@R85] Medication errors can result from any step of the medication-use process: selection and procurement, storage, ordering and transcribing, preparing and dispensing, administration, or monitoring.[@R1]Non-prescription drugs: Medicines that can be sold legally without a drug prescription.Over-the-counter (OTC) drug: The Food and Drug Administration defines OTC *drugs as 'drugs that have been found to be safe and appropriate for use without the supervision of a health care professional such as a physician, and they can be purchased by consumers without a prescription'*.[@R86]Prescription drug: Drugs that cannot be sold legally without a prescription.

Methods {#s2}
=======

Protocol and reporting {#s2a}
----------------------

The study protocol was developed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and was registered in PROSPERO.[@R10] The detailed systematic review protocol has also been published.[@R12]

Eligibility criteria/study selection {#s2b}
------------------------------------

Studies conducted in adults (≥18 years) who were looked after in the community and living in their own or family homes without home healthcare or nursing home were eligible for inclusion in this review. The studied patients could have been self-managing, receiving care in primary care or ambulatory care settings, or any combination of the above. Studies were included if they were population-based, cross-sectional or cohort studies, which were suitable to estimate the incidence and prevalence of medication errors or ADEs. These study designs and case--control studies were considered eligible to study risk factors for the development of error-related ADEs. Studies with prescribed and/or over-the-counter (OTC) medications as the exposure of interest were eligible.

Paediatric studies (\<18 years) and studies on patients receiving care in hospital at home settings (ie, continuous medical and/or nursing care provided to patients in their own homes), in nursing homes, as hospitalised inpatients or in emergency departments (ED) were excluded. Randomised controlled trials were excluded since these could not be used to reliably assess the incidence and/or prevalence of the outcomes of interest. Existing reviews were also excluded since the focus was on the primary literature. Incompletely reported studies, for example, in the form of abstracts, were not eligible for inclusion. Studies on illegal substance abuse, herbal products and those focusing on particular medications were also excluded.

No restriction on the language of publication was employed.

Data sources and search strategy {#s2c}
--------------------------------

Search terms were developed based on the systematic review protocol.[@R12] The search terms and detailed search strategies are presented in online [supplementary appendix 1](#SP1){ref-type="supplementary-material"}. In summary, these involved identifying search terms (and their synonyms) in relation to medication safety, community care settings and study design, and combining these concepts with the Boolean operator AND to identify studies that intersected all three search concepts of interest. Examples of the search terms used included the following: for the outcome: medication safety, medication error, preventable adverse drug event and patient error; for the setting: ambulatory care, outpatient, self-care, primary healthcare and general practice; and for the study design: cohort study, cross sectional study and observational study. Six biomedical databases were searched, including the Cumulative Index to Nursing and Allied Health Literature, EMBASE, Eastern Mediterranean Regional Office of the WHO, MEDLINE, PsycINFO and Web of Science, between 1 January 2006 and 31 December 2015. Google Scholar was searched for additional studies. An international panel of experts was also contacted to identify unpublished work and research in progress (online [supplementary appendix 1](#SP1){ref-type="supplementary-material"}). The reference list of all included studies was further reviewed for additional possible eligible studies.
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The databases were searched by GAA. The title and abstracts were then independently screened for eligible studies according to the above detailed selection criteria by GAA and a second reviewer, NAS. The corresponding authors of the eligible articles were contacted if additional information was needed. Disagreements were resolved by discussion between the reviewers or by arbitration by a third reviewer, AS, if a decision could not be reached. Full-text articles were retrieved from selected studies and reviewed according to the selection criteria. Each copy of the selected studies was retrieved and the reason for excluding other studies was clearly noted.

Data extraction and risk of bias assessment {#s2d}
-------------------------------------------

Data were independently extracted and recorded onto a customised data extraction sheet by two reviewers (GAA and NAS, or GAA and MAM). Discrepancies were resolved by discussion or by arbitration by an additional reviewer (AS), if necessary.

Key information, such as study design, study type (retrospective, prospective), population of interest, exposure of interest, outcomes of interest and main findings, was extracted.

The risk of bias assessment was independently carried out on each study by two reviewers (GAA and NAS, or GAA and NA) using the Critical Appraisal Skills Programme (CASP) quality assessment tool for cohort and case--control studies,[@R13] and cross-sectional studies were assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for descriptive studies.[@R14] Any disagreements were resolved by consensus or by arbitration by a third reviewer (AS) if a decision could not be reached. Each study was given an overall grading as being at high, medium or low risk of bias.

Data synthesis {#s2e}
--------------

Data were summarised in detailed data tables, which included information on the incidence, prevalence, relative risk and ORs, together with 95% CIs, for each study (where available). A descriptive and narrative synthesis of the extracted data was undertaken.

The following is the definition of incidence rate used in this review: *'the number of patients with one or more \[medication error or preventable ADE\] (numerator) divided by the total number of patients at risk per time unit (denominator)'*. [@R15] The following is the definition of prevalence rate used in the data extraction: *'the number of patients experiencing one or more \[medication error or preventable ADE\] (numerator) divided by the total number of patients in the study population (denominator)'*. [@R16] The prevalence rate per population was either reported and extracted directly from the included study or calculated from data provided in the study.

We worked with the definitions of medication errors and error-related ADEs employed in individual studies. These errors may have occurred anywhere in the medicines' management process.[@R1] Medication errors were described according to (1) the stage in the medicines' management process when the error occurred, that is, prescribing, dispensing, administration and monitoring[@R1]; and (2) the type of error that occurred in each stage according to the conceptual framework for the International Classification for Patient Safety (ICPS) definitions ([box 2](#B2){ref-type="boxed-text"}).[@R17] Box 2Classification of definitions used in this systematic reviewAdministration error: 'Any discrepancy between how the medication is given to the patient and the administration directions from the physician or hospital guidelines'.[@R1]Prescribing error: 'Medication error occurring during the prescription of a medicine that is about writing the drug order or taking the therapeutic decision, appreciated by any non-intentional deviation from standard reference such as: the actual scientific knowledge, the appropriate practices usually recognized, the summary of the characteristics of the medicine product, or the mentions according to the regulations. A prescribing error notably can concern: the choice of the drug (according to the indications, the contraindications, the known allergies and patient characteristics, interactions whatever nature it is with the existing therapeutics, and the other factors), dose, concentration, drug regimen, pharmaceutical form, route of administration, duration of treatment, and instructions of use; but also the failure to prescribe a drug needed to treat an already diagnosed pathology, or to prevent the adverse effects of other drugs'.[@R17]Inappropriate prescribing: 'The use of medicines that introduce a significant risk of an adverse drug-related event where there is evidence for an equally or more effective but lower-risk alternative therapy available for treating the same condition. Inappropriate prescribing also includes the use of medicines at a higher frequency and for longer than clinically indicated, the use of multiple medicines that have recognized drug--drug interactions and drug--disease interactions, and importantly, the under-use of beneficial medicines that are clinically indicated but not prescribed for ageist or irrational reasons'.[@R87]Monitoring error: 'Failure to review a prescribed regimen for appropriateness and detection of problems, or failure to use appropriate clinical or laboratory data for adequate assessment of patient response to prescribed theory'.[@R17]Dispensing error: 'Deviation from the prescriber's order, made by staff in the pharmacy when distributing medications to nursing units or to patients in an ambulatory pharmacy setting'.[@R17]Other discrepancies:'Any differences between the medication described by the patient and caregivers with the drugs listed by their general practitioners (GP) or between the medications listed in the discharge letter for the primary care physician with those in the patient discharge medication list'.[@R31]

Risk factors were categorised as patient, healthcare professional and medication-related risk factors.

Changes from the original protocol {#s2f}
----------------------------------

The following changes were made from the plans described in the research protocol[@R12]: (1) due to the large quantity of studies found during the initial search and because of medications and practice changes over the years, only studies published in the last 10 years were included: 1 January 2006--31 December 2015; (2) only studies with the incidence or prevalence rate per number of patients were included; and (3) meta-analysis was not possible due to the heterogeneity of outcomes, methods and definitions.

Results {#s3}
=======

A total of 13 033 potentially eligible studies were identified after removing duplicates, of which 59 studies met the inclusion criteria. One additional study was identified through hand-searching. Therefore, a total of 60 studies were included in the systematic review ([figure 1](#F1){ref-type="fig"}).

![PRISMA flow diagram (from Moher *et al* [@R88]). CINAHL, Cumulative Index to Nursing and Allied Health Literature; EMRO, Eastern Mediterranean Regional Office; RCT, randomised controlled trial. \*Articles may be duplicated between the excluded groups.](bmjopen-2017-019101f01){#F1}

One study was available only in German and one in Spanish. Those two papers were retrieved and translated into English by native speakers.[@R18]

The key characteristics of all included studies are presented in [table 1](#T1){ref-type="table"}. The quality assessments of these studies are summarised in [tables 2A and 2B](#T2A T2B){ref-type="table"}.

###### 

Systematic review data extraction table

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Key characteristics of included studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- ------------------------------------------------------------------------------ ------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------
  Self-reported medication errors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  1\.                                                                                                                                   Adam *et al*, 2009[@R72]                  Australia                                                                      Cross-sectional                                  Analysis of data from 3522 adults participating in stage 2 of the North West Adelaide Health Study aged ≥18 years                                                         Unclear                                                                                Self-reported adverse event (medication, diagnosis and others).\                                                                                                                                                                                                                                     Of the total 3522 survey participants, 148 (4.2%) reported an adverse event causing harm in the previous 12 months, giving an annual incidence of 4.2% (95% CI 3.4% to 5.0%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                       Medication error prevalence: 68/3522=1.9%                                                                                                                            Subjective data rather\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using survey.                                                                                                                                                                                                                                                                                        Medication error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        than objective
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The main types of adverse events perceived as causing harm were medication error (reported by 46% of the 148 participants reporting adverse events).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  2\.                                                                                                                                   Lu and Roughead, 2011[@R20]               Australia, Canada, New Zealand, UK, USA, Germany and The Netherlands           Cross-sectional (secondary analysis)             11 910 adult respondents aged ≥18 years.\                                                                                                                                 Prescribed drug                                                                        Self-reported medication error and compare factors associated with medication errors across the seven countries.\                                                                                                                                                                                    Self-reported medication errors prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Medication error prevalence: 752/11 910=6.3%                                                                                                                         Prevalence for medication error alone\
                                                                                                                                                                                                                                                                                                                  Data from the 2007 Commonwealth Fund International\                                                                                                                                                                                                              Using survey.                                                                                                                                                                                                                                                                                        752 respondents had medication error (Australia=7.4%; Canada=5.7%; New Zealand=5.9%; UK=5.2%; USA=7%; Germany=5.2%; The Netherlands=8%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 from table 1, while the\
                                                                                                                                                                                                                                                                                                                  Health Policy Survey.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Risk factors across countries included seeing multiple specialists, multiple chronic conditions, hospitalisation and multiple emergency room visits.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      risk factors for both\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  medical and medication\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  error.

  3\.                                                                                                                                   Sears *et al*, 2012[@R21]                 Australia, Canada, France, Germany, the Netherlands, New Zealand, UK and USA   Descriptive (secondary/retrospective analysis)   9944 adults aged ≥18 years from the\                                                                                                                                      Taking medication regularly                                                            Patient-related risk factors associated with self-reported medication errors.\                                                                                                                                                                                                                       Medication error prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Medication error prevalence: 570/9944=5.7%                                                                                                                           Risk factors for both\
                                                                                                                                                                                                                                                                                                                  community setting                                                                                                                                                                                                                                                Using telephone survey.                                                                                                                                                                                                                                                                              570 respondents with medication errors occurring in the community setting. Approximately 4 out of every 5 self-reported medication errors occurred in the community setting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              hospital and community\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  setting

  4\.                                                                                                                                   Mira *et al*, 2013[@R73]                  Alicante, Spain                                                                Cross-sectional                                  382 elderly aged ≥65 years from primary care.\                                                                                                                            Prescribed and self-medications                                                        Frequency of mistakes in communication between the physician and the patient and their medication error in the last year.\                                                                                                                                                                           Medication error prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Medication error prevalence: 287/382=75%                                                                                                                             Consequence\*
                                                                                                                                                                                                                                                                                                                  Patients on polypharmacy (five or more drugs) and with comorbidity: cardiovascular (51.6%); diabetes\                                                                                                                                                            Using semistructured interviews.                                                                                                                                                                                                                                                                     75.1% of the patients reported having made at least one mistake with the medication in the last year.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                  (34.3%).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Multiple comorbidities (p=0.006), frequent changes in prescription (p=0.02), not considering the prescriptions of other physicians (p=0.01), inconsistency in the messages (p=0.01), being treated by various different physicians at the same time (p=0.03), a feeling of not being listened to (p\<0.001) or loss of trust in the physician (p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \*The error due to drug confusion had very severe consequences, requiring a visit to the emergency service or hospital admission.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Risk factors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  5\.                                                                                                                                   Sorensen *et al*, 2006[@R76]              4 states of Australia                                                          Cross-sectional, prospective                     204 general practice patients living in their own home aged 37--99 years                                                                                                  Prescribed drugs                                                                       Prevalence and interrelationships of medication-related risk factors for poor patient health outcomes identifiable through 'in-home' visit observations.                                                                                                                                             Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Prevalence of nominal medication-related risk factors and health outcomes among the sample of 204 patients.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Multiple medication storage locations used=17 (8.3%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Expired medication present=40 (19.6%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Discontinued medication repeats retained=43 (21%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        4. Hoarding of medications=43 (21%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        5. Therapeutic duplication present=50 (24.5%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Administration error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        6. No medication administration routine=56 (27.5%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        7. Poor adherence=107 (52.5%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        8. Confused by generic and trade names=114 (55.9%).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  6\.                                                                                                                                   Vuong and Marriott, 2006[@R25]            Melbourne, Australia                                                           Descriptive                                      142 discharged adults aged ≥55 years who were returning to independent care at home.\                                                                                     Discharge prescribed drugs                                                             Unnecessary medicine stored at home as a risk factor.\                                                                                                                                                                                                                                               Unnecessary medicine stored at home prevalence: 85/142=60%.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Unnecessary medicine stored at home prevalence: 85/142=60%                                                                                                           No information on how\
                                                                                                                                                                                                                                                                                                                  Patients at risk of medication misadventure.                                                                                                                                                                                                                     Using home visit within 5 days of discharge.                                                                                                                                                                                                                                                         85 (60%) of 142 patients who received a home visit allowed removal of medicines that had expired or no longer required.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  many patients had\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Prescribing error: drug duplication prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          unnecessary medicine.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        32 (27%) patients allowed removal of 82 duplicate packs of the same item that was no longer required.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Information available is\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        A total of 390 medicines were removed with a mean of 4.6 medicines per patient (range 1--21).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             on the patient allowed to\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  remove unnecessary\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  medicine.

  7\.                                                                                                                                   Pit *et al*, 2008[@R74]                   New South Wales, Australia.                                                    Cross-sectional study                            849 elderly aged ≥65 years from general practice                                                                                                                          Self-medications                                                                       Prevalence of self-reported risk factors for medication misadventures.\                                                                                                                                                                                                                              Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \*ADR as a risk factor for\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Tool used: Medication Risk Assessment Form (patient survey)                                                                                                                                                                                                                                          1. Using at least one medication for more than 6 months (95%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           medication\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. More than one doctor involved in their care (59%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    misadventure may not\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Had three or more health conditions (57%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            be related to the use of\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        4. Used five or more medicines (54%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    medication in all cases.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        5. ADRs, in the last month 39% of participants experienced difficulties sleeping, felt drowsy or dizzy (34%), had a skin rash (28%), leaked urine (27%), had stomach problems (22%) or had been constipated (22%).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  8\.                                                                                                                                   Mosher *et al*, 2012[@R75]                Iowa, USA                                                                      Cohort prospective                               310 elderly aged ≥65 years who were cognitively intact from a Veterans Administration primary care clinic                                                                 Taking five or more non-topical medications                                            Association of health literacy with medication knowledge, adherence and ADEs.\                                                                                                                                                                                                                       Total: 310 patients\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Low health literacy increased the risk of ADEs.                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using interview and chart review.                                                                                                                                                                                                                                                                    Prevalence of ADEs:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ADEs occurred in 51 patients (16.5%) of the patients within the first 3 months of the study, which increased to 119 patients (38.4%) over the full 12-month follow-up period.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factor:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Association of health literacy with ADEs:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The incidence of ADEs at 3 and 12 months appeared higher among patients with low health literacy, but this was not statistically significant.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Medicines' management process:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  9\.                                                                                                                                   Koper *et al*, 2013[@R23]                 Austria                                                                        Descriptive                                      169 patients from general practice taking five or more medicines.\                                                                                                        Prescribed and OTC drug                                                                Medication errors including non-evidence-based medications, dosing errors and potentially dangerous interactions in all patients.\                                                                                                                                                                   Prescribing error prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Medication error prevalence:\                                                                                                                                        A medication was\
                                                                                                                                                                                                                                                                                                                  Mean age: 76.4±8.5 SD years.\                                                                                                                                                                                                                                    Potential interactions were identified using the Lexi-Interact database.\                                                                                                                                                                                                                            Indication:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1. Non-evidence-based medications: 158/169=93.5%.\                                                                                                                   classified as non-\
                                                                                                                                                                                                                                                                                                                  Of the 169 patients, 158 were elderly aged ≥65 years.                                                                                                                                                                                                            PIMs in subgroup of elderly patients according to the PRISCUS list.\                                                                                                                                                                                                                                 158 of the 169 patients (93.5%) had at least one non-evidence-based medication.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     2. Dosing error: 74/169=43.8%.\                                                                                                                                      evidence-based if the\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using case report form filled by the GPs.                                                                                                                                                                                                                                                            Dosing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       3. Category D drug\                                                                                                                                                  indication for use\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        74 of the 169 patients (43.8%) had at least one dosing error.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       interaction: 99/168=58%; category X drug interaction: 4/168=2.4%.\                                                                                                   indicated by the GP\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        DDI prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     4. PIMs: 59/158=37.3%.                                                                                                                                               was not mentioned in\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Category D interactions: 99 patients (58%) had at least one category D interaction.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      any peer-reviewed\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Category X interactions: 4 patients (2.4%) had at least one category X interaction.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      chapter of UpToDate.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        PIM prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        59 of seniors (37.3%) had at least one medication that was inappropriate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  10\.                                                                                                                                  Mand *et al*, 2014[@R33]                  Germany                                                                        Descriptive retrospective                        24 619 elderly aged ≥65 years from family practice with at least one diagnosis named in the Beers list                                                                    Prescribed drug                                                                        PDDI frequency and whether there are gender-related or age-related differences.\                                                                                                                                                                                                                     Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PDDI prevalence: 2560/24 619=10.4%                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Analysis from electronic patient records.                                                                                                                                                                                                                                                            Contraindication or drug--disease interaction prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        10.4% of elderly were exposed to at least one PDDI.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Patients over 75 years (OR 1.10, CI 1.05 to 1.15).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Number of drugs prescribed (\>4 drugs: OR 1.91, CI 1.83 to 2.00).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Blood clotting disorders/receiving anticoagulant therapy (OR 2.38, CI 2.15 to 2.64) showed the strongest association with PDDI.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  11\.                                                                                                                                  Gagne *et al*, 2008[@R36]                 Regione Emilia-Romagna, Italy                                                  Cohort retrospective                             4 222 165 regional Emilia-Romagna residents.\                                                                                                                             Prescribed drug                                                                        Clinically important potential DDI.\                                                                                                                                                                                                                                                                 Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 7893/14 906=53%                                                                                                                                      Risk factors for all age groups including paediatrics. All age\
                                                                                                                                                                                                                                                                                                                  Outpatient aged from 0 to ≥85 years.                                                                                                                                                                                                                             Risk factors.\                                                                                                                                                                                                                                                                                       DDI prevalence: exposed to potential DDI adults (19 to ≥85 years)=7893.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  groups included so results should be considered cautiously.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Outpatient prescription data from the Regional Emilia-Romagna.\                                                                                                                                                                                                                                      Unexposed adult=7013.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: a list of clinically important potential DDIs included 12 drug pairs that could be captured using the regional Emilia-Romagna database.                                                                                                                                          Total=14 906.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  12\.                                                                                                                                  Dallenbach *et al*, 2007[@R24]            Geneva, Switzerland                                                            Descriptive, retrospective file review           591 outpatients, mean age\                                                                                                                                                Prescription drug and drug currently taking                                            Clinically significant ADI.\                                                                                                                                                                                                                                                                         Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 135/591=23%                                                                                                                                          
                                                                                                                                                                                                                                                                                                                  39 years                                                                                                                                                                                                                                                         Prescription review.\                                                                                                                                                                                                                                                                                DDI prevalence: In 135 of the consultations, a potentially clinically significant ADI was identified.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: DDI compendia and (ePocrates RX) with clinical decision support.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  13\.                                                                                                                                  Obreli Neto *et al*, 2011[@R26]           Brazil                                                                         Cross-sectional                                  2627 elderly aged 60--88 years from the primary healthcare                                                                                                                Prescribed drug                                                                        Potential risks in drug prescriptions: DDI and PIM.\                                                                                                                                                                                                                                                 Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 3.1%--29.1%\                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using prescription review.\                                                                                                                                                                                                                                                                          DDI prevalence: Using DrugDigest showed that 4.7% and 28.4% of the elderly presented at least one potential DDI classified as major and moderate, respectively.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                     PIM prevalence: 26.9%                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: (DrugDigest, Medscape and Micromedex).\                                                                                                                                                                                                                                          Using Medscape showed that 3.4% and 19.3% of the elderly presented at least one potential DDI classified as major and moderate, respectively.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PIM using Beers criteria 2003.                                                                                                                                                                                                                                                                       Using Micromedex showed that 3.1% and 29.1% of the elderly presented at least one potential DDI classified as major and moderate, respectively.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        PIM prevalence: 26.9% of the patients had prescriptions with at least one PIM.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  14\.                                                                                                                                  Secoli *et al*, 2010[@R30]                Sao Paulo, Brazil                                                              Cross-sectional                                  2143 community-dwelling elderly aged ≥60 years.\                                                                                                                          ≥2 prescribed drug use                                                                 Potential DDIs and identify associated factors.\                                                                                                                                                                                                                                                     Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 568/2143=26.5%                                                                                                                                       
                                                                                                                                                                                                                                                                                                                  Data were obtained from the SABE (Health, Well-Being and Ageing) survey.                                                                                                                                                                                         Using home interview.\                                                                                                                                                                                                                                                                               DDI prevalence: 568/2143=26.5%.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: Micromedex Healthcare Series.                                                                                                                                                                                                                                                    Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The use of six or more medications (OR 3.37, 95% CI 2.08to 5.48) or having hypertension (OR 2.56, 95% CI 1.73 to 3.79), diabetes (OR 1.73, 95% CI 1.22to 2.44) or heart problems (OR 3.36, 95% CI 2.11 to 5.34) significantly increased the risk of potential DDI.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  15\.                                                                                                                                  Obreli Neto *et al*, 2012[@R27]           5 cities of Brazil                                                             Cross-sectional                                  12 343 elderly aged ≥60 years from the primary public health system                                                                                                       Prescription for two or more drugs (prescribed both within and across prescriptions)   Potential DDIs (presence of a minimum of 5 days overlap in supply of an interacting drug pair) and predictor of DDI.\                                                                                                                                                                                12 343 patients (5855 exposed; 6488 unexposed).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     DDI prevalence: 5855/12 343=47.4%                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using medical prescriptions and patients' medical records review.\                                                                                                                                                                                                                                   Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: DDI checker programmes (DrugDigest, Drugs, Micromedex and Medscape).                                                                                                                                                                                                             DDI prevalence: 47.4%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Female sex (OR=2.49 (95% CI 2.29 to 2.75)), diagnosis of ≥3 diseases (OR=6.43 (95% CI 3.25 to 12.44)) and diagnosis of hypertension (OR=1.68 (95% CI 1.23 to 2.41)) were associated with potential DDIs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Age was associated with an increasing risk of DDIs. Number of prescribers, number of drugs consumed, ATC codes and drugs that act on CYP450 presented positive associations with potential DDIs in univariate and multivariate analyses of drug therapy characteristics.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  16\.                                                                                                                                  Indermitte *et al*, 2007[@R34]            Switzerland                                                                    Descriptive                                      434 passer-by customers aged ≥18 years from community pharmacies                                                                                                          Prescription-only medicines and OTC drug                                               Potential drug interactions.\                                                                                                                                                                                                                                                                        Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 3/102=3%, 69/434=16%, 116/434=26.7%                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1. Observation of customer contacts and interviews with passer-by customers purchasing selected OTC drugs.\                                                                                                                                                                                          DDI prevalence: Observation of passer-by customers.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2. Telephone interviews with regular customers treated with selected prescription-only medicines identified in community pharmacies' databases.\                                                                                                                                                     Of 1183 passer-by customers observed, 164 purchased at least one of the selected OTC drugs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: Pharmavista database.                                                                                                                                                                                                                                                            102 (62.2%) of those subjects were interviewed. 43 (42.2%) mentioned taking prescribed drugs and 3 of them were exposed to potential drug interactions of moderate severity.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Telephone interview with regular customers.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Out of 592 regular customers selected from the community pharmacy database, 434 (73.3%) could be interviewed.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Prevalence of DDI in regular customers:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        69 (15.9%) of them were exposed to a potential drug interaction between purchased OTC drug for self-medication and their prescription-only medicines.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Furthermore, 116 (26.7%) regular customers were exposed to potential drug interactions within their prescribed drugs and in 28 (6.5%) multiple (\>2) potential drug interactions were found.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  17\.                                                                                                                                  Mahmood *et al*, 2007[@R35]               USA                                                                            Cross-sectional, retrospective                   2 795 345 patients who filled prescriptions for medications involved potential DDI from 128 Veterans Affairs medical centres.\                                            Prescribed drug                                                                        Clinically important DDI.\                                                                                                                                                                                                                                                                           Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 2.15%                                                                                                                                                Age not mentioned
                                                                                                                                                                                                                                                                                                                  Ambulatory care clinic.                                                                                                                                                                                                                                          Database analysis of pharmacy records.\                                                                                                                                                                                                                                                              DDI prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: a list of 25 potential DDI.                                                                                                                                                                                                                                                      The overall rate of potential DDIs was 21.54 per 1000 veterans exposed to the object or precipitant medications of interest.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  18\.                                                                                                                                  Lapi *et al*, 2009[@R37]                  Dicomano, Italy                                                                Cohort, a two-wave, population-based survey      568 community-dwelling elderly aged ≥65 years                                                                                                                             Prescription and non-prescription drugs used at least 1 week before enrolment          Suboptimal prescribing:\                                                                                                                                                                                                                                                                             Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potential DDI prevalence: 30.5%, p\<0.001\                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Inappropriate medication=1991 Beers criteria (13 items out of the original 39 (33.3%) Beers list medications were considered).\                                                                                                                                                                      Potential DDI prevalence was significantly higher in 1999 compared with 1995 (30.5% vs 20.1%; p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Inappropriate medication prevalence: 5.1%, p=0.004                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: Micromedex Drug-Reax system.\                                                                                                                                                                                                                                                    Inappropriate prescriptions were significantly higher in 1995 compared with 1999 (9.1% vs 5.1%; p=0.004).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using population-based survey.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

                                                                                                                                        1995                                      1999                                                                           P values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Inappropriate medication                                                                                                              47 (9.1%)                                 26 (5.1%)                                                                      0.004                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  DDI                                                                                                                                   97 (20.1%)                                147 (30.5%)                                                                    \<0.001                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Major DDI                                                                                                                             20 (4.7%)                                 24 (5.6%)                                                                      0.585                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Polypharmacy always predicted a substantial increase in the risk of the PIM and DDI.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  19\.                                                                                                                                  Nobili *et al*, 2009[@R38]                Lecco, Italy                                                                   Cross-sectional, retrospective                   58 800 community-dwelling elderly aged ≥65 years registered under the local health\                                                                                       Receiving at least two coadministered prescriptions                                    DDIs and associated risk factors (age, sex and number of prescriptions).\                                                                                                                                                                                                                            Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potentially severe DDI prevalence: 9427/58 800=16%                                                                                                                   Only the interactions identified as severe were considered in these analyses.
                                                                                                                                                                                                                                                                                                                  authority of Lecco                                                                                                                                                                                                                                               DDI screening tool: Italian computerised interaction database. Analysed all prescriptions dispensed from 1 January 2003 to 31 December 2003.                                                                                                                                                         DDI prevalence: 9427 elderly people (16%) were exposed to drug combinations with the potential for 13 932 severe DDIs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Mean number of DDI per patient was 0.2 (range 0--9).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Age and number of chronic drugs were associated with an increasing risk of DDIs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The adjusted OR increased from 1.07 (95% CI 1.3 to 1.11) in patients aged 70--74 years to 1.52 (95% CI 1.46 to 1.60) in those aged 85 or older.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Elderly taking more than five chronic drugs had a statistically significant higher risk of potentially severe DDIs (OR=5.59, 95% CI 5.39 to 5.80) than those receiving less than 3 (reference category) or 3--5 chronic drugs (OR=2.71, 95% CI 2.63 to 2.80).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  20\.                                                                                                                                  Guthrie *et al*, 2015[@R39]               Scotland, UK                                                                   Cross-sectional                                  311 881 residents aged ≥20 years from the community-dispensed prescribing data (general practice).\                                                                       Prescribed drugs                                                                       Potentially serious DDI.\                                                                                                                                                                                                                                                                            Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  DDI prevalence: 13 615/308 660=4.4%                                                                                                                                  Resident living in both\
                                                                                                                                                                                                                                                                                                                  Living in own home: 308 660.                                                                                                                                                                                                                                     Patient characteristics associated with the presence of potentially serious DDI.\                                                                                                                                                                                                                    DDI prevalence: 40 689 adults (13%) had potentially serious DDI in 2010 (for both residents living in own home and care home).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           care home or own home.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: analysis of community-dispensed prescribing data using British National Formulary 2010.                                                                                                                                                                                          Number of patient with potentially serous DDI for residence living in their own home in 2010=13 615.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Risk factors for own\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  home and care home.

  21\.                                                                                                                                  Maio *et al*, 2006[@R40]                  Emilia-Romagna, Italy                                                          Cohort retrospective                             849 425 elderly outpatients aged ≥65 years from the Emilia-Romagna outpatient prescription claims database                                                                Prescribed drugs                                                                       PIM using the 2002 Beers criteria and factors associated with PIM.\                                                                                                                                                                                                                                  Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 152 641/849 425=18%                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Prescription review.                                                                                                                                                                                                                                                                                 PIM prevalence: A total of 152 641 (18%) elderly had one or more occurrences of PIM prescribing.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Older age (≥85 years) (OR 1.18, 95% CI 1.16 to 1.2, p\<0.05).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. ≥10 drugs prescribed (OR 7.33, 95% CI 7.15 to 7.51, p\<0.05).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. ≥4 chronic conditions (OR 1.76, 95% CI 1.72 to 1.81, p\<0.05).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  22\.                                                                                                                                  de Oliveira Martins *et al*, 2006[@R41]   Lisbon, Portugal                                                               Cross-sectional                                  213 elderly aged ≥65 years from 12 community pharmacies                                                                                                                   Prescription and home medications                                                      IDU by 1997 Beers and 2003 Beers explicit criteria.\                                                                                                                                                                                                                                                 Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IDU prevalence: 59/213=27.7% using 1997 Beers\                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using survey.                                                                                                                                                                                                                                                                                        PIM prevalence: Using the 1997 Beers explicit criteria, 75 occurrences of inappropriate medicines were detected in 59 patients (27.7%). Using the 2003 Beers explicit criteria inappropriate medication was detected in 82 patients (38.5%).\                                                                                                                                                                                                                                                                                                                                                                                        IDU prevalence: 82/213=38.5% using 2003 Beers                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The occurrence of inappropriate medicines was significantly associated with the consumption of a high number of drugs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  23\.                                                                                                                                  Pugh *et al*, 2006[@R42]                  Austin, Texas, USA                                                             Cross-sectional, retrospective                   1 096 361 outpatient elderly aged ≥65 years using national data from the Veterans Health Administration                                                                   Prescribed drug only                                                                   Potentially IP included in the 2006 HEDIS criteria and to determine if patient risk factors are similar to those found using Beers criteria.\                                                                                                                                                        Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potentially IP prevalence: 214 887/1 096 361=19.6%                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using database.                                                                                                                                                                                                                                                                                      IP prevalence: Overall, 19.6% of older veterans were exposed to HEDIS 2006 drugs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Patients receiving ≥10 medications were at greatest risk of exposure in men (OR 8.2, 95% CI 8 to 8.4) and women (OR 9.6, 95% CI 8.2 to 11.2).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Patients with more outpatient clinic visits (≥10) were at greater risk regardless of gender (OR 1.4, 95% CI 1.3 to 1.6).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Diagnosis with other mental illness (eg, depression, anxiety) alone or in combination with serious mental illness was associated with higher risk of potentially IP for women (OR 1.3, 95% CI 1.1 to 1.5).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  24\.                                                                                                                                  Saab *et al*, 2006[@R43]                  Lebanon                                                                        Descriptive                                      277 elderly aged ≥65 years from 10 community pharmacies                                                                                                                   Prescription and/or OTC medications                                                    IDU (Beers criteria, missing doses, inappropriate frequency of administration, poor memory, drug--disease interaction, DDI, inappropriate dose, duplicated therapy, discontinuation of therapy, adverse effect and inappropriate indication).\                                                       Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IDU prevalence: 62/277=22.4% using Beers criteria                                                                                                                    Just extracted the IDU by Beers criteria because the IDU includes 5 cases of ADR and some patients had more than one IDU.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Factors that predict potentially inappropriate drug intake.\                                                                                                                                                                                                                                         PIM prevalence: The prevalence of elderly outpatient with at least one inappropriate medication: 165/277 (59.6%) (include five patients with ADR).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Risk factors for all types of\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Review patient profile using community pharmacy data and inperson interviews.                                                                                                                                                                                                                        Inappropriate medication use was most frequently identified in terms of Beers criteria (22.4%), missing doses (18.8%) and incorrect frequency of administration (13%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   IDU.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Drug--disease interaction in 28 patients (10.1%), DDI 14 (5.1%), duplicate therapy 12 (4.3%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Female sex (65.7% vs 53.3% for male, p=0.03).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        There were also significant associations between the likelihood of use of an inappropriate drug and (1) increased number of medical illnesses (p\<0.00002); (2) consumption of an OTC drug and/or prescription drug (p=0.048 and p=0.0035, respectively); and (3) consumption of both OTC and prescription drugs (p\<0.0002).                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  25\.                                                                                                                                  Zuckerman *et al*, 2006[@R44]             USA                                                                            Cohort retrospective                             487 383 community-dweller elderly aged ≥65 years.\                                                                                                                        Prescribed drug                                                                        Inappropriate medication use using Beers criteria                                                                                                                                                                                                                                                    Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Inappropriate medication use prevalence: 204 083/487 383=41.9%                                                                                                       
                                                                                                                                                                                                                                                                                                                  Data from MarketScan Medicare Supplemental and Coordination of Benefits database.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     PIM prevalence: 204 083 elderly used inappropriate medication.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Use of inappropriate drugs was associated with a 31% increase in risk of nursing home admission, compared with no use of inappropriate drugs (adjusted relative risk 1.31, 99% CI 1.26 to 1.36).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  26\.                                                                                                                                  Bregnhøj *et al*, 2007[@R45]              Copenhagen, Denmark                                                            Cross-sectional                                  212 elderly aged ≥65 years with polypharmacy (≥5 drugs) patients from primary care                                                                                        Subsidised and non-subsidised medications prescribed                                   IP measured by the MAI: 10 criteria are indication, effectiveness, dosage, directions practicality, directions correctness, DDI, drug--disease interaction, duplication, duration and expense).\                                                                                                     Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IP prevalence: 200/212=94.3%                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Patients exposed to polypharmacy were identified via the database recording the drug subsidy system of Danish pharmacies and questionnaire.                                                                                                                                                          IP prevalence: The majority of the patients, namely 94.3%, had one or more inappropriate ratings among their medications.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  27\.                                                                                                                                  Johnell and Fastbom, 2008[@R46]           Sweden                                                                         Cross-sectional                                  731 105 people aged ≥75 years from the Swedish Prescribed Drug Register (secondary data analysis)                                                                         Prescribed drug only and multidose drug dispensing                                     Whether the use of multidose drug dispensing is associated with potential IDU (ie, anticholinergic drugs, long-acting benzodiazepines, concurrent use of ≥3 psychotropic drugs and combinations of drugs that may lead to potentially serious DDIs).\                                                Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence:\                                                                                                                                                     Multidose drug dispensing means that patients get their drugs machine-dispensed into one unit for each dose occasion and packed in disposable bags.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Information from the Swedish Prescribed Drug Register.                                                                                                                                                                                                                                               PIM prevalence: Prevalence of potential IDU in multidose dispensing users: 40.3% (women: 41%, men: 38.5%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Multidose dispensing users: 292 737/731 105=40%\                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Prevalence of potential IDU In prescription users: 13.6% (women: 15%, men: 11.5%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Prescription users: 99 430.3/731 105=13.6%                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The multidose users had higher prevalence of all indicators of potential inappropriate drug than prescription users.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. The younger elderly (aged 75--79 years) who used multidose drug dispensing had the highest frequency of all indicators of potential IDU.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Most indicators of IDU were more common in women than men.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Multidose drug dispensing among those aged 75--79 years old was even more strongly associated with any IDU, anticholinergic drugs, three or more psychotropic drugs in both men and women, and long-acting benzodiazepines among men.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  28\.                                                                                                                                  Berdot *et al*, 2009[@R47]                Dijon, Bordeaux, Montpellier, France                                           Cohort prospective                               6343 community-dwelling elderly aged ≥65 years                                                                                                                            Prescribed drug                                                                        PIM using 1997 and 2003 Beers criteria, Fick and Laroche.\                                                                                                                                                                                                                                           Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 2004/6343=31.6%, p\<0.001                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Face-to-face interview using standardised questionnaire.                                                                                                                                                                                                                                             PIM prevalence: One-third (31.6%) of the study participants reported using at least one inappropriate medication at study entry.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  29\.                                                                                                                                  Haider *et al*, 2009[@R48]                Sweden                                                                         Cross-sectional, register-based study            626 258 older people aged 75--89 years from the Swedish Prescribed Drug Register (secondary data analysis)                                                                Prescribed drug only                                                                   If low education associated with potential IDU (ie, anticholinergic drugs, long-acting benzodiazepines, concurrent use of ≥3 psychotropic drugs and clinically relevant potential DDI).\                                                                                                             Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IDU prevalence: 216 685/626 258=34.6%                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Information from the Swedish Prescribed Drug Register.                                                                                                                                                                                                                                               PIM prevalence: The proportion of participants reporting use of at least one potential IDU was 34.6%.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Subjects with low education had a higher probability of potential IDU (OR 1.09, 95% CI 1.07 to 1.17).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Older age, being a woman and higher CCI were associated with the highest frequencies of potential IDU.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  30\.                                                                                                                                  Lai *et al*, 2009[@R49]                   Taiwan                                                                         Descriptive                                      2 133 864 patients aged ≥65 years between 2001 and 2004 from ambulatory care National Health Insurance claim database                                                     Prescribed drug                                                                        PIM prescribing using updated 2003 Beers criteria and the characteristics of and risk factors for such prescribing                                                                                                                                                                                   Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence:\                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        PIM prevalence: A mean of 63.8% of the older population received a PIM at least once a year in 2001--2004.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2001: 65.7%\                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Details:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2002: 64.7%\                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2001: 1 974 869 patients of whom 1 297 425 had inappropriate prescription (65.7).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2003: 62.3%\                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2002: 2 026 737 patients of whom 1 312 147 had inappropriate prescription (64.7).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2004: 1 333 792/2 133 864=62.5%                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2003: 2 077 677 patients of whom 1 295 227 had inappropriate prescription (62.3).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2004: 2 133 864 patients of whom 1 333 792 had IP (62.5).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The only patient characteristic associated with an increased likelihood of the prescribing of PIM was female sex (male sex: OR 0.982 (95% CI 0.980 to 0.983)) (p\<0.001) and when ≥4 drugs were prescribed (p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The following are physician characteristics associated with a greater likelihood of the prescribing of PIM:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Male sex (OR 1.206, 95% CI 1.202 to 1.210, p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Older age (43--50 years: OR 1.021, 95% CI 1.018 to 1.025, p\<0.001; ≥51 years: OR 1.238, 95% CI 1.235 to 1.242, p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Family medicine/general practice (OR 1.267, 95% CI 1.265 to 1.269, p\<0.001).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  31\.                                                                                                                                  Ryan *et al*, 2009[@R50]                  Ireland                                                                        Cohort prospective                               500 patients aged ≥65 years from primary care                                                                                                                             Prescribed drug                                                                        IP using 2003 Beers criteria and IPET.\                                                                                                                                                                                                                                                              Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IP prevalence:\                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Screening patients' medical records (electronic and paper).                                                                                                                                                                                                                                          PIM prevalence: 65 patients (13%) and 52 patients (10.4%) had at least one medicine prescribed inappropriately using 2003 Beers and IPET criteria, respectively.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Beers 2003: 65/500=13%\                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             IPET: 52/500=10.4%                                                                                                                                                   

  32\.                                                                                                                                  Ryan *et al*, 2009[@R51]                  Cork, Southern Ireland                                                         Descriptive case record review                   1329 elderly aged ≥65 years from primary care                                                                                                                             Prescribed drugs                                                                       A---1. PIM using 2003 Beers and STOPP criteria.\                                                                                                                                                                                                                                                     Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence:\                                                                                                                                                     Spearman's ρ correlation\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2. PPO using START criteria.\                                                                                                                                                                                                                                                                        PIM prevalence: IP rate identified by Beers criteria in 18.3% (243) of patients.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Beers: 243/1329=18.3%\                                                                                                                                               test
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   B---Relationship between age and number of prescription drugs and IP.\                                                                                                                                                                                                                               IP rate identified by STOPP was 21.4% (284).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        STOPP: 284/1329=21.4%\                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Case record through paper and electronic record review.                                                                                                                                                                                                                                              PPO was identified in 22.7% (302) of patients using the START tool.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 PPO prevalence:\                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       START: 302/1329=22.7%                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        A significant correlation was found between the occurrence of PIM and the following:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. The number of medicines prescribed when calculated using Beers criteria (r~s~=0.270, p\<0.01) and STOPP (r~s~=0.356, p\<0.01) using Spearman's ρ correlation test.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Age using Beers criteria (r~s~=0.068, p\<0.01) and STOPP (r~s~=0.071, p\<0.01).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Increasing CCI score identified by STOPP (r~s~=0.210, p\<0.01).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  33\.                                                                                                                                  Akazawa *et al*, 2010[@R52]               Tokyo, Japan                                                                   Cohort retrospective                             6628 elderly patients aged ≥65 years from health insurance claim data (secondary data analysis)                                                                           Prescribed drugs                                                                       PIM using modified Beers criteria in Japan.\                                                                                                                                                                                                                                                         Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 2889/6628=43.6%                                                                                                                                      \*Consequence
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Drug utilisation review using medical and pharmacy claim from database of Japan Medical Data Center.                                                                                                                                                                                                 PIM prevalence: 43.6% (2889/6628) were prescribed at least one PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Factors positively associated with PIM prescriptions at a significance level of 5% included the following: hospital admission (OR=3.35, 95% CI 2.43 to 4.62); polypharmacy (OR=5.69, 95% CI 5 to 6.48); prescriptions from a hospital (OR=1.19), general medicine practitioner (OR=1.46) or psychiatrist/neurologist (OR=2.33); and comorbid conditions including peptic ulcer disease without bleeding (OR=4.18, 95% CI 3.52 to 4.97), depression (OR=3.69), cardiac arrhythmias (OR=1.93), other neurological disorders (Parkinson's disease, multiple sclerosis and epilepsy; OR=1.88) and congestive heart failure (OR=1.46).\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        PIM users had significantly higher hospitalisation risk (1.68-fold), more outpatient visit days (1.18-fold) and higher medical costs (33% increase) than did non-users.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  34\.                                                                                                                                  Zaveri *et al*, 2010[@R53]                Ahmedabad city, India                                                          Descriptive prospective                          407 geriatric patients aged ≥65 years from medicine outpatient department                                                                                                 Prescribed drug                                                                        PIM using 2003 Beers criteria.\                                                                                                                                                                                                                                                                      Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 96/407=23.6%                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using prospective proforma data collection.                                                                                                                                                                                                                                                          PIM prevalence: Out of 407 patients, 96 patients (23.6%) received at least one drug that was potentially inappropriate.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        There was highly significant association between the number of drugs prescribed and frequency of use of PIMs (p\<0.0002).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  35\.                                                                                                                                  Barnett *et al*, 2011[@R54]               Tayside, Scotland, UK                                                          Cohort                                           65 742 elderly aged 66--99 years living in home                                                                                                                           Prescribed drug                                                                        PIM using 2003 Beers criteria and the association between exposure to PIM and mortality.\                                                                                                                                                                                                            Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 20 304/65 742=30.9%                                                                                                                                  Risk factors for both care\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using dispensing and prescribing database and medical record.                                                                                                                                                                                                                                        PIM prevalence: PIM found in 20 304 (30.9%) patients living at home.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     home and home
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        After adjustment for age, sex and polypharmacy,\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Patient at increased risk of receiving at least one PIM if they were younger, female and had higher polypharmacy.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Receiving at least one PIM was [not]{.ul} associated with increased risk of mortality (adjusted OR 0.98, 95% CI 0.92 to 1.05).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  36\.                                                                                                                                  Chang *et al*, 2011[@R55]                 Taipei, Taiwan                                                                 Cohort                                           193 outpatient elderly patients aged ≥65 years with polypharmacy (≥8 chronic medications) from Medication Safety Review Clinic in Taiwanese Elders (MSRC-Taiwan) study    Prescribed drugs and dietary supplement excluding herbals                              PIM using six different criteria and drug-related problem: the 2003 version of the Beers criteria (from the USA), the Rancourt (from Canada), the Laroche (from France), STOPP (from Ireland), the Winit-Watjana (from Thailand) and the NORGEP criteria (from Norway).\                             Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 24%--73%                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Analyse baseline data from the MSRC-Taiwan study.\                                                                                                                                                                                                                                                   PIM prevalence: The proportion of patients who had at least one PIM varied from 24% (the NORGEP criteria) to 73% (the Winit-Watjana criteria).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Secondary data analysis.                                                                                                                                                                                                                                                                             Approximately 31% (the STOPP criteria) to 42% (the NORGEP criteria) of PIMs identified were considered as drug-related problems by the medication review team experts.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        In the bivariate analysis, the common characteristics associated with having at least one PIM in [all criteria]{.ul} were a high number of chronic conditions and a high number of chronic medications.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  37\.                                                                                                                                  Leikola *et al*, 2011[@R56]               Finland                                                                        Cross-sectional                                  841 509 non-institutionalised elderly patients aged ≥65 years from Finland's Social Insurance Institution prescription register of all reimbursed drugs for outpatients   Prescribed and OTC medications that are reimbursed                                     PIM using 2003 Beers criteria                                                                                                                                                                                                                                                                        Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 123 545/841 509=14.7%                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        PIM prevalence: 14.7% (n=123 545) had received PIMs according to the Beers 2003 criteria.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  38\.                                                                                                                                  Lin *et al*, 2011[@R57]                   Taiwan                                                                         Cross-sectional, retrospective analysis          327 elderly patients aged ≥65 years from outpatient clinic of a community health centre                                                                                   Prescribed drugs                                                                       PIM using 2003 Beers criteria and risk factors of PIM use.\                                                                                                                                                                                                                                          Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 90/327=27.5%                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using data review.                                                                                                                                                                                                                                                                                   PIM prevalence: The prevalence of patients having at least one PIM was 27.5% (90/327).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Independent risk factors for PIMs are older age (OR=1.05, 95% CI 1.00 to 1.09, p=0.046), higher number of prescribed medications (OR=1.06, 95% CI 1.39 to 1.98, p\<0.001) and diagnosis of acute diseases (OR=8.98, 95% CI 4.71 to 17.1, p\<0.001).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  39\.                                                                                                                                  Woelfel *et al*, 2011[@R70]               California, USA                                                                Cross-sectional                                  295 elderly aged ≥65 years from ambulatory population of Medicare beneficiaries                                                                                           Prescribed drug                                                                        PIM using 2003 Beers criteria.\                                                                                                                                                                                                                                                                      Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 54/295=18.3%                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using medication review                                                                                                                                                                                                                                                                              PIM prevalence: 54 (18.3% beneficiaries were taking at least one PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The number of medications was significantly greater in the PIM than the non-PIM group (p\<0.001).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  40\.                                                                                                                                  Zhang *et al*, 2011[@R58]                 USA                                                                            Cohort retrospective                             3570 elderly community-based respondents aged ≥65 from 2007 MEPS, a nationally representative survey of the US community-dwelling population                              Prescribed drug                                                                        PIM using Zhan criteria and risk factors for PIM use.\                                                                                                                                                                                                                                               Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 13.84%--21.3%                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Information from MEPS database.                                                                                                                                                                                                                                                                      PIM prevalence: PIM prevalence in 2007: 13.84% (CI 12.52 to 15.17).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        PIM prevalence in 1996: 21.3% (CI 19.5 to 23.1).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Older women, people taking ≥25 prescriptions, people with middle family income, people living in the South census region, and people who said they were in fair or poor health were more likely to have received an inappropriate medication during the year.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  41\.                                                                                                                                  Haasum *et al*, 2012[@R59]                Sweden                                                                         Cross-sectional, retrospective                   1 260 843 home-dwelling elderly aged ≥65 years from the Swedish Prescribed Drug Register                                                                                  Prescribed drug only                                                                   Potentially IDU (use of anticholinergic drugs, long-acting benzodiazepines, concurrent use of ≥3 psychotropics and potentially serious DDIs).\                                                                                                                                                       Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potentially IDU prevalence: 145 749/1 260 843= 11.6%                                                                                                                 Information on both\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Information from the Swedish Prescribed Drug Register.                                                                                                                                                                                                                                               PIM prevalence: 11.6% of the home-dwelling elderly were exposed to potentially IDU.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       institutionalised and\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  home-dwelling.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Extracted home-dwelling\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  information only.

  42\.                                                                                                                                  Candela Marroquí *et al*, 2012[@R19]      Cáceres, Spain                                                                 Descriptive                                      471 patients aged ≥65 years from health centres                                                                                                                           Consumed medications                                                                   Potentially IP using STOPP/START criteria.\                                                                                                                                                                                                                                                          Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potentially IP prevalence: 249/471=52.8% (95% CI\                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using patient interview and medical chart review.                                                                                                                                                                                                                                                    PIM prevalence: 249 patients (52.8%, 95% CI 48.3 to 57.3) had potentially IP according to STOPP/START criteria.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     48.3 to 57.3)                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        STOPP: 162 patients (34.3%, 95% CI 30.2% to 38.8%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        START: 114 patients (24.2%, 95% CI 20.5% to 28.2%).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  43\.                                                                                                                                  Nyborg *et al*, 2012[@R60]                Norway                                                                         Cross-sectional, retrospective                   445 900 home-dwelling elderly aged ≥70 years from the\                                                                                                                    Prescribed drug                                                                        Prevalence of and predictors for PIM use by the NORGEP criteria.\                                                                                                                                                                                                                                    Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 155 341/445 900= 34.8% (99% CI\                                                                                                                      
                                                                                                                                                                                                                                                                                                                  Norwegian Prescription Database                                                                                                                                                                                                                                  Survey undertaken based on data from the Norwegian Prescription Database.                                                                                                                                                                                                                            PIM prevalence: 34.8% of the study population was exposed to at least one PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      34.7 to 35)                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The odds of receiving potentially harmful prescriptions increased with the number of doctors involved in prescribing (OR 3.52, 99% CI 3.44 to 3.60 for those with ≥5 compared with those with 1 or two prescribers).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Women were at higher risk for PIMs (OR 1.6, 99% CI 1.58 to 1.64).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  44\.                                                                                                                                  Yasein *et al*, 2012[@R61]                Jordan                                                                         Cross-sectional                                  400 elderly aged ≥65 years from family practice clinic                                                                                                                    Prescribed drug                                                                        Polypharmacy (≥5 drugs) and IP using 2003 Beers criteria.\                                                                                                                                                                                                                                           Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  IP prevalence: 118/400=29.5%                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using patient file and patient interview.                                                                                                                                                                                                                                                            PIM prevalence: Inappropriate medications as determined by Beers criteria independent of diagnosis accounted for 118 (29.5%) patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  45\.                                                                                                                                  Blozik *et al*, 2013[@R62]                Helsana, Switzerland                                                           Cohort                                           2008: 1 059 495\                                                                                                                                                          Prescribed drug submitted for reimbursement                                            Prevalence of polypharmacy and PIM using 2003 Beers criteria or the PRISCUS list.\                                                                                                                                                                                                                   Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 21.1%                                                                                                                                                There are huge discrepancies in estimating the prevalence of PIM depending on the definition used.
                                                                                                                                                                                                                                                                                                                  2009: 1 047 939\                                                                                                                                                                                                                                                 Using analysis of data based on claim data from Switzerland health insurance.                                                                                                                                                                                                                        PIM prevalence: According to 2003 Beers criteria, 10.3% of the community-dwelling population aged \>65 years received at least one medication which is PIM, and according to the [PRISCUS list 1]{.ul}, 16.0% of persons had a PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                  2010: 929 791\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        When using both Beers and PRISCUS criteria, 21.1% of the population received at least one PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                  Community-dwelling adults aged \>18 years from claim data of Helsana                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Of those persons older than 65 years asking for reimbursement of medications, 12.9% received at least one PIM according to 2003 Beers, 20.2% according to PRISCUS and 26.6% of either definition.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Women were more likely to receive a PIM: 25.5% of women as compared with 15.4% of men when both Beers and PRISCUS definitions were used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  46\.                                                                                                                                  Cahir *et al*, 2013[@R63]                 Ireland                                                                        Cohort retrospective                             931 community-dwelling elderly aged ≥70 years from 15 general practices                                                                                                   Prescribed drug and OTC                                                                The association between potentially IP using STOPP and health-related outcomes (ADEs, HRQOL, and hospital accident and ED).\                                                                                                                                                                         Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potentially IP prevalence: 377/931=40.5%\                                                                                                                            \*Consequence.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using patient self-report and medical record.                                                                                                                                                                                                                                                        PIM prevalence: Prevalence of potentially IP was 40.5% (n=377).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ADE prevalence: 674/859=78%                                                                                                                                          Type of ADE was not\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ADE prevalence: In total, 674 of 859 participants (78%) were classified as having at least one ADE during the study period.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              mentioned.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Patients with ≥2 potentially IP indicators were:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Twice as likely to have an ADE (adjusted OR 2.21, 95% CI 1.02 to 4.83, p\<0.05).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. Significantly lower mean HRQOL utility (adjusted coefficient −0.09, SE 0.02, p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. A twofold increased risk in the expected rate of ED visits (adjusted incidence rate ratio 1.85, 95% CI 1.32 to 2.58, p\<0.001).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  47\.                                                                                                                                  Weng *et al*, 2013[@R64]                  Taiwan                                                                         Cross-sectional, retrospective                   780 older patients aged ≥65 years from the outpatient geriatric clinic                                                                                                    Long-term prescribed drugs (≥28 days) for chronic diseases, not\                       Impact of number of drugs prescribed on the risk of PIM using STOPP criteria.\                                                                                                                                                                                                                       Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 302/780=39%                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            OTC                                                                                    Patient medical chart review.                                                                                                                                                                                                                                                                        PIM prevalence: 302 patients (39%) had at least one PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Multivariate analysis revealed that PIM risk was associated with the number of medications prescribed (p\<0.001) and the presence of cardiovascular (p\<0.001) or gastrointestinal disease (p=0.003).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Patients prescribed ≥5 drugs (adjusted OR=5.4) had significantly higher PIM risk than those prescribed ≤2 drugs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  48\.                                                                                                                                  Zimmermann *et al*, 2013[@R18]            German                                                                         Cohort longitudinal analysis                     Follow-up 3: n=1942\                                                                                                                                                      Prescribed drug                                                                        PIM using Beers, PRISCUS list.\                                                                                                                                                                                                                                                                      Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Prescribing error:\                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                  Baseline: n=3214\                                                                                                                                                                                                                                                By checking medications during visits to patients' homes.                                                                                                                                                                                                                                            PIM prevalence: At baseline, PIM prevalence is 29% (848) (according to the PRISCUS list, which decreased to 25.0% (464) 4.5 years later (χ^2^: 7.87, p=0.004).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                      PIM prevalence: 17%--29%                                                                                                                                             
                                                                                                                                                                                                                                                                                                                  1855 elderly aged ≥75 years from primary care.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       The Beers list yielded a prevalence of 21% (620) at baseline, decreasing after 4.5 years to 17.1% (317) (χ^2^: 10.77, p=0.000).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                  Data from the prospective, multicentre, observational study 'German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)'.                                                                                                                                                                                                                                                                                                                                                                                                                      Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        By PRISCUS list:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The risk for PIM increase with:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Increasing age of the patients (OR: 1.06, CI 1.00 to 1.13, p=0.037).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. The presence of depression (OR: 2.42, CI 1.65 to 3.57, p=0.000).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Increasing number of prescription drugs (OR: 1.99, CI 1.80 to 2.18, p=0.000).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        By contrast, the risk of taking PIM decrease by using PRISCUS list with the number of present illness (OR: 0.88, CI 0.80 to 0.97, p=0.012).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        As the growing number of ingested prescription drugs increased the risk for the ingestion of PIM from the Beers list (OR: 1.66, CI 1.50 to 1.84; p=0.000).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  49\.                                                                                                                                  Baldoni *et al*, 2014[@R29]               Ribeirao Preto, Brazil                                                         Cross-sectional                                  1000 elderly aged ≥60 years from outpatient pharmacy                                                                                                                      Prescribed drug, self-medication (309 users) and OTC (802 users)                       Prevalence and factors associated with PIM using 2003 and 2012 Beers criteria.\                                                                                                                                                                                                                      Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence by Beers criteria 2003: 480/1000= 48.0%\                                                                                                              \*Error-related adverse event
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using structured interview questionnaire.                                                                                                                                                                                                                                                            PIM prevalence: According to Beers criteria 2003, 480 (48.0%) participants used at least one PIM, the mean being 1.38 (SD=0.65) PIMs/person, ranging from 1 to 5.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PIM prevalence by Beers criteria 2012: 592/1000= 59.2%                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        According to Beers criteria 2012, 592 (59.2%) participants used at least one PIM, the mean being 1.56 (SD=0.81) PIMs/person, ranging from 1 to 6.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ADE: During the interview 45.5% of participants reported complaints related to ADEs; 94.5% of these were caused by prescribed medication.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Factors that are associated with PIMs use were female gender, self-medication, use of OTC medications, complaints related to ADEs, psychotropic medication and more than five medications.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \*Ten medications with the highest prevalence of self-reported ADEs complaints are clonidine, amitriptyline, metformin, fluoxetine, dexchlorpheniramine, diclofenac, captopril, acetylsalicylic acid, simvastatin and hydrochlorothiazide. Among them, five were considered PIMs according to Beers criteria, of which clonidine, amitriptyline and dexchlorpheniramine are listed in both criteria, while fluoxetine is listed only in Beers criteria 2003 and diclofenac is listed only in Beers criteria 2012.                                                                                                                                                                                                                                                                                         

  50\.                                                                                                                                  Castillo-Páramo *et al*, 2014[@R65]       Spain                                                                          Cross-sectional                                  272 electronic records of elderly aged ≥65 years from primary healthcare                                                                                                  Prescribed drugs                                                                       PIM using STOPP/START criteria and version adapted to Spanish primary healthcare and factors may modulate PIM onset.\                                                                                                                                                                                Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 102/272 (STOPP)=37.5% (95% CI 31.7 to 43.2), 138/272 (STOPP AP2012)=50.7% (95% CI 44.7 to 56.6), 125/272 (START)=45.9%, 117/272 (START AP2012)=43%   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using electronic health record and paper clinical record.                                                                                                                                                                                                                                            PIM prevalence: The prevalence of PIM (misprescribing and overprescribing) using the STOPP original criteria was 37.5% (95% CI 31.7 to 43.2), and 50.7% (95% CI 44.7 to 56.6) using the STOPP Spanish AP2012 version.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The prevalence of underprescribing was 45.9% (95% CI 40.0 to 51.8) with the START original criteria, and 43.0% (95% CI 37.1 to 48.9) with the START AP2012 version.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        A significant correlation was found between the number of STOPP PIM and age or number of prescriptions, and between the number of START PIM with age, CCI and number of prescriptions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  51\.                                                                                                                                  Vezmar Kovačević *et al*, 2014[@R66]      Serbia Belgrade                                                                Cross-sectional, prospective                     509 elderly aged ≥65 years from five community pharmacies                                                                                                                 Prescribed drug                                                                        PIM and PPO using STOPP/START criteria.\                                                                                                                                                                                                                                                             Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 139/509=27.3%\                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using patient interview and medical, biomedical record.                                                                                                                                                                                                                                              PIM prevalence: There were 164 PIMs identified in 139 patients (27.3%) by STOPP and 439 PPOs identified in 257 patients (50.5%) by START.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           PPO prevalence: 257/509=50.5%                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Patients with more than four prescriptions had a higher risk for PIM (OR 2.85, 95% CI 1.97 to 4.14, p\<0.001) and ≥9 medications (OR 7.43, 95% CI 3.20 to 17.23, p\<0.001).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Patients older than 74 years were more likely to have a PPO (75--84 years: OR 1.47, 95% CI 1.01 to 2.13, p=0.041; and ≥85 years: OR 1.79, 95% CI 1.19 to 2.83, p=0.009).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  52\.                                                                                                                                  Amos *et al*, 2015[@R67]                  Emilia-Romagna, Italy                                                          Cohort retrospective                             865 354 elderly aged ≥65 years community-dwelling from administrative care data                                                                                           Prescribed drug only                                                                   PIM using updated Maio criteria and patient characteristics related to IP.\                                                                                                                                                                                                                          Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM prevalence: 240 310/865 354=28%                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using regional Emilia-Romagna administrative healthcare database.                                                                                                                                                                                                                                    PIM prevalence: A total of 240 310 (28%) older adults were exposed to at least one PIM.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The oldest group (≥85) followed by patients aged 75--84 had 53% and 25% greater odds of receiving PIM than patients 65--75 years old, respectively (OR=1.53, 95% CI 1.50 to 1.55; OR=1.25, 95% CI 1.23 to 1.26, respectively).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        These odds of exposure to any PIM were slightly lower among men than women (OR=0.98, 95% CI 0.97 to 1.00).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        An increase in the number of medications prescribed to the patient corresponded with higher odds of PIM exposure.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Older GPs (≥56), male GPs and solo practice GPs were more likely to prescribe PIMs to their older patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  53\.                                                                                                                                  Hedna *et al*, 2015[@R68]                 Sweden                                                                         Cohort retrospective                             542 elderly aged ≥65 years from the Swedish Total Population Register (primary\                                                                                           Prescribed drug                                                                        Prevalence of potentially IPs using STOPP criteria and to investigate the association between potentially IPs and occurrence of ADRs.\                                                                                                                                                               Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Potentially IP prevalence: 226/542=42%                                                                                                                               \*Error-related adverse\
                                                                                                                                                                                                                                                                                                                  care)                                                                                                                                                                                                                                                            Using the Swedish Prescribed\                                                                                                                                                                                                                                                                        PIM prevalence: 226 patients using primary healthcare had potentially IP.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                event.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Drug Register, medical records and health administrative data.                                                                                                                                                                                                                                       Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            The association between\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Persons prescribed potentially IP had more than twofold increased odds to experience ADRs (OR 2.47, 95 % CI (1.65 to 3.69), p\<0.001), compared with that in persons without potentially IP.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              PIPs and occurrence of\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ADRs was for primary\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  care, outpatient or\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  inpatient and hospitalised\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  patients.

  54\.                                                                                                                                  Moriarty *et al*, 2015[@R69]              Ireland                                                                        Cohort prospective                               2051 elderly aged ≥65 years from The Irish Longitudinal Study on ageing.\                                                                                                 Prescribed drug only                                                                   PIM and PPO using STOPP, Beers criteria, ACOVE indicators and START.\                                                                                                                                                                                                                                Prescribing error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PIM: 36.7%--64.8%                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                  Community-dwelling elderly.                                                                                                                                                                                                                                      Using face-to-face interview, then follow-up after 1 and 2 years.                                                                                                                                                                                                                                    PIM prevalence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                        Baseline\                                 Follow-up\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                        N (%) (95% CI)                            N (%) (95% CI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Any PIM using STOPP, Beers, ACOVE                                                                                                     1259 (61.4%) (CI 59.3\                    1330 (64.8%) (CI 62.8\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                        to 63.5)                                  to 66.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Any PPO using START, ACOVE                                                                                                            1094 (53.3%) (CI 51.2\                    1161 (56.6%) (CI 54.5\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                        to 55.5)                                  to 58.8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Both PIM and PPO                                                                                                                      753 (36.7%)                               843 (41.1%)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Female sex, age and higher number of medicines were significantly associated with change in PIM prevalence.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Age and higher numbers of medicines and chronic conditions were found to be significantly associated with change in PPO prevalence.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  55\.                                                                                                                                  Ramia and Zeenny, 2014[@R71]              Lebanon                                                                        Cross-sectional                                  284 outpatients aged ≥18 years visiting community pharmacy                                                                                                                Patients on ≥1 of the chronic medications mentioned in the study                       The completion of therapeutic/safety monitoring tests.\                                                                                                                                                                                                                                              Monitoring error:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Incomplete therapeutic/safety laboratory-test monitoring prevalence: 208/284=73%                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Patients were subjected to a questionnaire assessing the appropriateness of their laboratory-test monitoring.                                                                                                                                                                                        1. 185 of the patients (65%) were found to complete some, but not all, of the recommended therapeutic/safety monitoring tests.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. 76 of the patients (27%) completed all recommended therapeutic/safety monitoring.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. 23 of the patients (8%) did not complete any of the recommended monitoring tests.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Other: discrepancies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  56\.                                                                                                                                  Tulner *et al*, 2009[@R31]                Amsterdam, The Netherlands                                                     Descriptive prospective                          120 elderly aged \>65 years from Dutch geriatric outpatient                                                                                                               Using more than one prescribed or OTC medications                                      1\. Frequency and relevancy of discrepancies in drug use.\                                                                                                                                                                                                                                           Other: discrepancies prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Discrepancies prevalence: 104/120=86.7%\                                                                                                                             \*Error-related adverse event
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2. Frequency of MDAPEs.\                                                                                                                                                                                                                                                                             At least one discrepancy (deletion, addition or difference in dosage) between the medication lists from the patient, the GP or the pharmacy was present in 104 patients (86.7%) involving 386 drugs.\                                                                                                                                                                                                                                                                                                                                                                                                                                \*Error-related adverse event: MDAPEs: 29/120=24.2%                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   3. Contributing factors such as increasing age, cognitive status and depressive symptoms, the number of medications used, and the number of physicians visited by the patient.\                                                                                                                      MDAPES:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   By comparing the medication described by the patient and caregivers with the drugs listed by their GP.                                                                                                                                                                                               MDAPES were identified in 29 patients (24.2%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        7 patients had undertreatment due to deletions.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        9 patients had ADR due to additions.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        13 patient had DDI.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Patients with ≥1 discrepancy reported using a higher mean number of drugs (5.9 vs 4.0; p\<0.05) and had more prescribing physicians in addition to their GP (1.1 vs 0.43; p\<0.05).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Both the presence of discrepancies (Pearson's r', 0.293; p=0.05) and MDAPEs (Pearson's r', 0.230; p=0.012) were significantly correlated with the number of medications reported by the patient.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \*The highest rates of discrepancies were seen for acetaminophen (86.7%), laxatives (82.9%) and formulations for dermatological or ophthalmological diseases (81.3%).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  57\.                                                                                                                                  Cornu *et al*, 2012[@R32]                 Brussels, Belgium                                                              Cohort retrospective                             189 elderly aged ≥65 years discharged from acute geriatric department of a Belgian university hospital                                                                    Prescribed drug                                                                        Incidence and type of discrepancies between the discharge letter for the primary care physician and the patient discharge medication and identify possible patient-related determinants for experiencing discrepancies.\                                                                             Other: discrepancies prevalence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Discrepancies prevalence: 90/189=47.6% (95% CI 40.5 to 54.7)                                                                                                         \*Error-related adverse event
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Discrepancies were categorised as omitted drug, unintended continuation (discontinued home medication documented as home medication), discrepant dose, missing dose, and discrepant brand, omission of a brand name, discrepant frequency, missing frequency or an incorrect pharmaceutical form.\   Almost half of these patients (n=90, 47.6%) (95% CI 40.5 to 54.7) had one or more discrepancies in medication information at discharge.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   By comparing the medications listed in the discharge letter for the primary care physician with those in the patient discharge medication list.                                                                                                                                                      \*Two discrepancies (1.2%) were categorised as having the potential to cause severe patient harm. These discrepancies consisted of a wrong dose (doubled the prescribed dose) of digoxin in the patient discharge medication list and the listing of a low-molecular-weight heparin in the patient discharge medication list that was intentionally omitted in the discharge letter because of the development of heparin-induced thrombocytopaenia during hospitalisation.\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The explorative multivariate model adjusted for age, sex, length of hospital stay and residential situation showed that when the discharge letter contained more than five drugs, the likelihood of experiencing one or more drug discrepancies was 3.22 (95% CI 1.40 to 7.42, p=0.006) times higher than when five or fewer drugs were mentioned.\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Increasing numbers of drugs in the discharge medication list (OR 1.19, 95% CI 1.07 to 1.32, p=0.001) and discharge letter (OR 1.18, 95% CI 1.07 to 1.32, p=0.001) were associated with a higher risk for discrepancies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Preventable ADEs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  58\.                                                                                                                                  Field *et al*, 2007[@R77]                 USA                                                                            Cohort                                           30 000 elderly ≥65 years from ambulatory care                                                                                                                             Prescribed drug                                                                        ADE resulting from patients error and risk factors.\                                                                                                                                                                                                                                                 Preventable ADE:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ADE resulting from patients' error prevalence: 113/30 000=0.38%                                                                                                      \*ADE resulting from patients' error
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   By electronic tracking of administrative data, review of medical records, reports from clinicians, hospital discharge summaries and ED visit.                                                                                                                                                        ADE resulting from patients' error prevalence: 113 individuals experienced ADE and potential ADE.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factor:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        In a multivariate analysis, there was a dose--response association between patient errors leading to ADEs and potential ADEs and regularly scheduled medications; compared with zero to two medications, the OR for three to four medications was 2.0 (95% CI 0.9 to 4.2); for five to six medications was 3.1 (95% CI 1.5 to 7.0); and for seven or more medications was 3.3 (95% CI 1.5 to 7.0).\                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The strongest association was with the CCI; compared with a score of 0, the OR for a score of 1--2 was 3.8 (95% CI 2.1 to 7.0); for a score of 3--4 was 8.6 (95% CI 4.3 to 17.0); and for a score of 5 or more was 15.0 (95% CI 6.5 to 34.5).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  59\.                                                                                                                                  Gandhi *et al*, 2010[@R22]                Boston and Indianapolis, USA                                                   Cross-sectional                                  68 013 outpatients, mean age 48 and 47 years                                                                                                                              Prescribed drug                                                                        ADE.\                                                                                                                                                                                                                                                                                                Preventable ADE incidence:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Preventable ADEs rate 15/1000 person-years across two sites                                                                                                          \*Preventable ADE
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Using electronic health record screening, chart review and ADE monitor.                                                                                                                                                                                                                              The overall rate was 138 ADEs/1000 person-years across the two sites. Preventable ADEs rate 15/1000 person-years across two sites.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \*Most common drugs associated with preventable ADE were ACE inhibitors and beta-blockers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  60\.                                                                                                                                  Obreli-Neto *et al*, 2012[@R28]           Ourinhos microregion,\                                                         Cohort prospective                               433 elderly aged ≥60 years from the primary public health system                                                                                                          Prescribed drugs both within and across prescriptions                                  DDI-related ADR incidence and factors.\                                                                                                                                                                                                                                                              Preventable ADE:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Incidence of DDI-related ADR: 30/433=6.9%                                                                                                                            \*Error-related adverse event
                                                                                                                                                                                  Brazil                                                                                                                                                                                                                                                                                                                                                                                           Using phone or face-to-face structured interview.\                                                                                                                                                                                                                                                   DDI-related ADR incidence: occurred in 30 patients (6.9%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   DDI screening tool: DDI checker programmes (DrugDigest, Drugs, Micromedex and Medscape).                                                                                                                                                                                                             Gastrointestinal bleeding occurred in 37% of the DDI-related ADR cases, followed by hyperkalaemia (17%) and myopathy (13%). Seventeen DDI-related ADRs were classified as severity level 2, and hospital admission was necessary in 11 cases.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \*Warfarin was the most commonly involved drug (37% of cases), followed by acetylsalicylic acid (17%), digoxin (17%) and spironolactone (17%).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Risk factors:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        The multiple logistic regression showed that the following were associated with the occurrence of DDI-related ADRs:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Age ≥80 years (OR 4.4, 95% CI 3.0 to 6.1, p\<0.01).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. CCI ≥4 (OR 1.3, 95% CI 1.1 to 1.8, p\<0.01).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        3. Consumption of five or more drugs (OR 2.7, 95% CI 1.9 to 3.1, p\<0.01).\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        4. Use of warfarin (OR 1.7, 95% CI 1.1 to 1.9, p\<0.01).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ACOVE, Assessing Care of Vulnerable Elders; ADE, adverse drug event; ADI, adverse drug interaction; ADR, adverse drug reaction; CCI, Charlson Comorbidity Index; DDI, drug--drug interaction; ED, emergency department; GP, general practitioners; HEDIS, Health Plan Employer Data and Information Set; HRQOL, health-related quality of life; IDU, inappropriate drug use; IP, inappropriate prescribing; IPET, improved prescribing in the elderly tool; MAI, Medication Appropriate Index; MDAPE, medication discrepancy adverse patient event; MEPS, Medical Expenditure Panel Survey; NORGEP, Norwegian General Practice; OTC, over-the-counter; PDDI, potential drug--disease interaction; PIM, potentially inappropriate medicine; PPO, potential prescribing omissions; START, Screening Tool to Alert doctors to Right Treatment; STOPP, Screening Tool of Older Person's Prescriptions.

###### 

Systematic review quality assessment: Joanna Briggs Institute Critical Appraisal Checklist for descriptive/case series and cross-sectional

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                  1                                                                          2   3                                                4                                                  5    6    7                                          8                                     9                                                                           Overall appraised   
  ---- ------------------------------------------ -------------------------------------------------------------------------- --- ------------------------------------------------ -------------------------------------------------- ---- ---- ------------------------------------------ ------------------------------------- --------------------------------------------------------------------------- ------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1    Ramia and Zeenny, 2014[@R71]\              Y                                                                          Y   N                                                N                                                  NA   NA   Y                                          Y                                     Y                                                                           High                Patients were subjected to a questionnaire assessing the appropriateness of their laboratory-test monitoring, may cause recall bias.
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  2    Sorensen *et al*, 2006[@R76]\              Y                                                                          Y   N, risk factors related to patient not studied   Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  3    Vuong and Marriott, 2006[@R25]\            U                                                                          Y   N                                                Y                                                  NA   NA   N                                          Y                                     Y, percentage was used but statistics was not described in the full text.   High                Unclear sampling strategy.
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  4    Adams *et al*, 2009[@R72]\                 Y                                                                          Y   Y (but for all types of adverse event)           N (self-reported adverse events)                   NA   NA   N                                          Y                                     Y                                                                           High                Risk of recall bias and attribution with self-reported adverse events.
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  5    Gandhi *et al*, 2010[@R22]\                U                                                                          Y   N                                                Y                                                  Y    NA   NA                                         Y                                     Y                                                                           High                
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  6    Lu and Roughead, 2011[@R20]\               Y                                                                          Y   Y                                                N (subjective patient-reported medication error)   Y    NA   NA (secondary analysis)                    N (telephone survey, self-reported)   Y                                                                           High                Risk of recall bias with patient-reported medication error.
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  7    Sears *et al*, 2012[@R21]\                 Y                                                                          Y   Y                                                N (subjective self-reported medication error)      Y    NA   NA (secondary analysis)                    N (telephone survey, self-reported)   Y                                                                           High                Risk of recall bias with patient self-reported medication error.
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  8    Koper *et al*, 2013[@R23]\                 N (convenience)                                                            Y   N                                                Y                                                  NA   NA   NA (100% participants)                     Y                                     Y                                                                           High                Selection bias.
       Adult                                                                                                                                                                                                                                                                                                                                                                                                                    

  9    Dallenbach *et al*, 2007[@R24]\            N (consecutive)                                                            N   N                                                Y                                                  NA   NA   NA (retrospective)                         Y                                     Y                                                                           Moderate            
       Adult-DDI                                                                                                                                                                                                                                                                                                                                                                                                                

  10   Indermitte *et al*, 2007[@R34]\            Y (pharmacy choose); N (first 12 customers)                                Y   N                                                Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                
       Adult-DDI                                                                                                                                                                                                                                                                                                                                                                                                                

  11   Mahmood *et al*, 2007[@R35]\               Y                                                                          Y   N                                                Y                                                  NA   NA   NA (retrospective)                         Y                                     Y                                                                           High                Patients may actually be on other drugs so may not catch all the DDI.
       Adult-DDI                                                                                                                                                                                                                                                                                                                                                                                                                

  12   Guthrie *et al*, 2015[@R39]\               Y                                                                          Y   Y (but for both own home and care home)          Y                                                  Y    NA   NA (secondary analysis)                    Y                                     Y                                                                           High                Risk factors for both own home and care home.
       Adult-DDI                                                                                                                                                                                                                                                                                                                                                                                                                

  13   de Oliveira Martins *et al*, 2006[@R41]\   N (first came to pharmacy carrying prescription for two or more drugs)     Y   Y, but not all                                   Y                                                  Y    NA   N                                          Y                                     Y                                                                           High                Self-reported data from elderly concerning drug use may lead to information bias.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  14   Pugh *et al*, 2006[@R42]\                  Y                                                                          Y   Y                                                Y                                                  Y    NA   NA (secondary data analysis)               Y                                     Y                                                                           High                May underestimate the exposure because they do not account for OTC.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  15   Saab *et al*, 2006[@R43]\                  Y                                                                          Y   Y                                                Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                Self-reported data from elderly concerning drug use may decrease accuracy.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  16   Bregnhøj *et al*, 2007[@R45]\              N (each GP was asked to recruit six patients who were randomly selected)   Y   N                                                Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                Selection bias.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  17   Johnell and Fastbom, 2008[@R46]\           Y                                                                          Y   Y                                                Y                                                  Y    NA   Y                                          Y                                     Y                                                                           High                Did not look for comorbidity as a risk factor because data were from Swedish Prescribing Drug Register.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  18   Haider *et al*, 2009[@R48]\                Y                                                                          Y   Y                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  19   Lai *et al*, 2009[@R49]\                   Y                                                                          Y   Y                                                Y                                                  NA   NA   NA (secondary analysis)                    Y                                     Y                                                                           High                Did not address comorbidity as a risk factor.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  20   Ryan *et al*, 2009[@R51]\                  Y                                                                          Y   Y                                                Y                                                  NA   NA   N                                          Y                                     Y                                                                           High                May underestimate the outcome because they do not account for OTC.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  21   Zaveri *et al*, 2010[@R53]\                U                                                                          Y   Y                                                Y                                                  NA   NA   N                                          Y                                     Y                                                                           High                Not enough information in the article.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  22   Leikola *et al*, 2011[@R56]\               Y                                                                          Y   N                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                May underestimate the outcome because database lacks diagnostic patient data, therefore used the Beers 2003 criteria independent of diagnoses and the data provide no information on the use of PIMs that are not reimbursable. Nine PIMs that were not reimbursable in Finland in 2007: triazolam, belladonna alkaloids, diphenhydramine, hydroxyzine, ferrous sulfate, bisacodyl, nitrofurantoin and clonidine.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  23   Lin *et al*, 2011[@R57]\                   U                                                                          Y   Y                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  24   Woelfel *et al*, 2011[@R70]\               Y                                                                          Y   Y                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  25   Haasum *et al*, 2012[@R59]\                Y                                                                          Y   N                                                Y                                                  Y    NA   NA (secondary data analysis)               Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  26   Nyborg *et al*, 2012[@R60]\                Y                                                                          Y   Y                                                Y                                                  Y    NA   NA (secondary data analysis)               Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  27   Yasein *et al*, 2012[@R61]\                N                                                                          Y   N                                                Y                                                  Y    NA   N                                          Y                                     Y                                                                           Moderate            
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  28   Candela Marroquín *et al*, 2012[@R19]\     N (convenience sample)                                                     Y   N                                                Y                                                  NA   NA   N                                          Y                                     Y                                                                           Moderate            Sampling strategy.\
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              Subjective information on socioeconomic and clinical variables may decrease accuracy.

  29   Weng *et al*, 2013[@R64]\                  Y                                                                          Y   Y                                                Y                                                  Y    NA   N                                          Y                                     Y                                                                           High                Sampling strategy.
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  30   Baldoni *et al*, 2014[@R29]\               U                                                                          Y   Y                                                Y                                                  Y    NA   Y                                          Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  31   Castillo-Páramo *et al*, 2014[@R65]\       Y                                                                          Y   Y                                                Y                                                  Y    NA   Y                                          Y                                     Y                                                                           High                Electronic health record use limitations (incomplete record and quality of data).
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  32   Vezmar Kovačević *et al*, 2014[@R66]\      Y                                                                          Y   Y                                                Y                                                  NA   NA   N                                          Y                                     Y                                                                           High                
       Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                              

  33   Nobili *et al*, 2009[@R38]\                Y                                                                          Y   Y                                                Y                                                  NA   NA   NA (administrative database)               Y                                     Y                                                                           High                The use of administrative database limits looking for comorbidity as a confounder.
       Elderly-DDI                                                                                                                                                                                                                                                                                                                                                                                                              

  34   Secoli *et al*, 2010[@R30]\                U                                                                          Y   Y                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                May underestimate the true DDI prevalence because they do not account for OTC.
       Elderly-DDI                                                                                                                                                                                                                                                                                                                                                                                                              

  35   Obreli Neto *et al*, 2012[@R27]\           Y                                                                          Y   Y                                                Y                                                  NA   NA   NA (data from primary healthcare system)   Y                                     Y                                                                           High                May underestimate the DDI prevalence because (1) most instruments available for assessing DDIs consider only pairs of drugs and do not account for interactions involving combinations of three or more drugs so (2) did not account for OTC.
       Elderly-DDI                                                                                                                                                                                                                                                                                                                                                                                                              

  36   Pit *et al*, 2008[@R74]\                   Y                                                                          Y   Y                                                Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                
       Elderly                                                                                                                                                                                                                                                                                                                                                                                                                  

  37   Tulner *et al*, 2009[@R31]\                N (consecutive)                                                            Y   Y                                                Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                Information on medication described by the patient and caregivers may not always be accurate.
       Elderly                                                                                                                                                                                                                                                                                                                                                                                                                  

  38   Obreli Neto *et al*, 2011[@R26]\           Y                                                                          Y   N                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                
       Elderly-DDI                                                                                                                                                                                                                                                                                                                                                                                                              

  39   Mira *et al*, 2013[@R73]\                  Y                                                                          Y   Y                                                Y                                                  NA   NA   Y                                          Y                                     Y                                                                           High                Self-reported medication error from elderly concerning drug use may have recall bias.
       Elderly                                                                                                                                                                                                                                                                                                                                                                                                                  

  40   Mand *et al*, 2014[@R33]\                  Y                                                                          Y   Y                                                Y                                                  NA   NA   NA                                         Y                                     Y                                                                           High                
       Elderly                                                                                                                                                                                                                                                                                                                                                                                                                  
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1 Was study based on a random or pseudo-random sample?

2 Were the criteria for inclusion in the sample clearly defined?

3 Were confounding factors identified and strategies to deal with them stated?

4 Were outcomes assessed using objective criteria?

5 If comparisons are being made, was there sufficient descriptions of the groups?

6 Was follow-up carried out over a sufficient time period?

7 Were the outcomes of people who withdrew described and included in the analysis?

8 Were outcomes measured in a reliable way?

9 Was appropriate statistical analysis used**?**

DDI, drug-drug interaction; GP, general practitioner; N, no; NA, not applicable; OTC, over-the-counter; PIM, potentially inappropriate medication; U, unclear; Y, yes.

###### 

Systematic review quality assessment: Critical Appraisal Skills Programme for cohort study

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                   Study design: cohort                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  ---------------------------------------------------------------- ---------------------------------- ------------------------------------- ----------------------- -------------------------------- --- ------------------------------------------------------------------------------------------------------------------------------------------------ ------------- --- ---------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- --- -------------------------------- --- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------
                                                                                                      Are the results of the study valid?   What are the results?   Will the results help locally?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  1                                                                Maio *et al*, 2006[@R40]\          Y                                     Y                       Y                                Y   Y, age, gender, geographical location, number of medication, number of chronic condition and income                                              N             Y   Y (1 year) retrospective           PIM prevalence: 18%.\                                                                                                                                       P\<0.05, 95% CI                               Y   Y                                Y   --                                                                                                                                                                                                                    Moderate
                                                                   PIM                                                                                                                                                                                                                                                                                                                                         Older age, polypharmacy and greater number of chronic conditions were significant predictors of PIM use.                                                                                                                                                                                                                                                                                                                                                                 

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  2                                                                Zuckerman *et al*, 2006[@R44]\     Y                                     Y                       Y                                Y   Y, but used for irrelevant outcome                                                                                                               Y             Y   Y (2 years)                        Inappropriate medication use prevalence: 41.9%                                                                                                              P=0.01, 99% CI                                Y   Cannot tell (generalisability)   Y   Limited information from the database.\                                                                                                                                                                               Moderate
                                                                   PIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Confounding factors were for the nursing home admission rather than for PIM.                                                                                                                                          

  \-                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  3                                                                Field *et al*, 2007[@R77]\         Y                                     Y                       Y                                Y   Y, age, gender, comorbidity, number of medications                                                                                               Y             Y   Y (1 year)                         ADE resulting from patients' error prevalence: 0.38%                                                                                                        P\<0.05                                       Y   Y                                Y   Possible drug-related incidence for which necessary information was not documented in the medical record was not considered.                                                                                          High
                                                                   Elderly                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  4                                                                Gagne *et al*, 2008[@R36]\         Y                                     Y                       Y                                Y   Y, age, gender, geographical location, comorbidity, number of medication prescribed                                                              Y             Y   Y (1 year)                         DDI: prevalence: 53%                                                                                                                                        95% CI                                        Y   Y                                Y   Applying the US list of clinically important DDI to Italy may underestimate the prevalence as it captured only 12 out of the 25 DDI original list. Unable to extract risk factors data as it is for all age groups.   High
                                                                   DDI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  5                                                                Berdot *et al*, 2009[@R47]\        Y                                     Y                       Y                                Y   Y, but for irrelevant outcome                                                                                                                    Y             Y   Y (4 years)                        PMI prevalence: 31.6%                                                                                                                                       95% CI, p\<0.05                               Y   Y                                Y   Self-report and data from healthcare insurance plan are not perfect for actual drug consumption. Recall bias.\                                                                                                        High
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Confounding factors were for the risk of falls rather than for PIM.                                                                                                                                                   

  --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  6                                                                Lapi *et al*, 2009[@R37]\          Y                                     Y                       Y                                Y   Y, comorbidity, polypharmacy, stroke, heart failure                                                                                              Y             Y   Y (1 year)                         1999:\                                                                                                                                                      P\<0.05, 95% CI                               Y   N                                Y   Self-reported diagnosis and medication use may cause recall bias.\                                                                                                                                                    Moderate
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 IP prevalence: 5.1%\                                                                                                                                                                                                                               Beers list cannot be fully applied to Italy; it most reflects US drug market.                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                               Potential DDI prevalence: 30.5%\                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                               Potential major DDI: 5.6%\                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                               Polypharmacy was a predictor of PIM use.                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Age, gender                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  7                                                                Ryan *et al*, 2009[@R50]\          Y                                     Y                       Y                                Y   N                                                                                                                                                Cannot tell   Y   Y (6 months)                       Medicine prescribed inappropriately.\                                                                                                                       Cannot tell                                   Y   Y                                Y   --                                                                                                                                                                                                                    Low
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 Beers 2003: 13%\                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                               IPET: 10.4%                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  --                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  8                                                                Akazawa *et al*, 2010[@R52]\       Y                                     Y                       Y                                Y   Y, age, gender, polypharmacy (\>5 drugs), hospitalisation, comorbidities                                                                         Y             Y   Y (1 year)                         Prevalence of PIM: 43.6%.\                                                                                                                                  95% CI, p\<0.05                               Y   Y                                Y   Medical information cannot be taken from claim data, unobserved confounder.\                                                                                                                                          High
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 Inpatient service use, polypharmacy and comorbidities were significant predictors of PIM use.                                                                                                                                                      PIM not associated with age as several other studies.                                                                                                                                                                 

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  9                                                                Barnett *et al*, 2011[@R54]\       Y                                     Y                       Y                                Y   Y, age, sex, polypharmacy and place of residence                                                                                                 Y             Y   Y (2 years)                        PIM prevalence: 30.9%.\                                                                                                                                     95% CI                                        Y   Y                                Y   Comorbidity not accounted for.\                                                                                                                                                                                       High
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 Patients at increased risk of receiving at least one PIM if they were younger, female and had higher polypharmacy.                                                                                                                                 Risk factors for both care home and home.                                                                                                                                                                             

  Comorbidity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  10                                                               Chang *et al*, 2011[@R55]\         Y                                     Y                       Y                                Y   Y, age, sex, education, number of chronic medication, number of chronic conditions and number of ED visits                                       Y             Y   Y (12, 24 weeks)                   PIM: 24%--73%\                                                                                                                                              P\<0.05                                       Y   Y                                Y   May underestimate the prevalence because several drugs in Taiwan were not available in the sex criteria.                                                                                                              High
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 Number of chronic drugs and number of chronic conditions were a common risk factor in all criteria.                                                                                                                                                                                                                                                                                                                                                                      

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  11                                                               Zhang *et al*, 2011[@R58]\         Y                                     Y                       Y                                Y   Y, race, gender, family income, educational level, census region, number of prescription, self-rated health status                               Y             Y   Cannot tell                        Prevalence of PIM was from 13.84% (95% CI 12.52 to 15.17) to 21.3% (95% CI 19.5 to 23.1).                                                                   95% CI, p\<0.05                               Y   Y                                Y   Recall bias due to self-reported survey. Did not assess DDI and underuse so may underestimate the prevalence.                                                                                                         Moderate
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  12                                                               Cornu *et al*, 2012[@R32]\         Y                                     Y                       Y                                Y   Y, age, gender, residential situation before admission, residential situation after discharge, number of drugs in the discharge letter or list   Y             Y   Y (from admission to discharge)    Almost half of these patients (47.6% (95% CI 40.5 to 54.7)) had one or more discrepancies in medication information at discharge.                           95% CI, p\<0.05                               Y   Cannot tell                      Y   Was done in one centre that may have different procedure of discharge.                                                                                                                                                Moderate
                                                                   Elderly                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Comorbidity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  13                                                               Mosher *et al*, 2012[@R75]\        Y                                     Y                       Y                                Y   Y, health literacy                                                                                                                               Y             Y   Y (3 and 12 months)                ADEs occurred in 51\                                                                                                                                        P\<0.05                                       Y   Cannot tell                      Y   Results may be biased due to sampling strategy.                                                                                                                                                                       Moderate
                                                                   Elderly                                                                                                                                                                                                                                                                                                                                     patients (16.5%) of the patients within the first 3 months of the study, which increased to 119 patients (38.4%) over the full 12-month follow-up period.                                                                                                                                                                                                                                                                                                                

  Age, number of medications, comorbidity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  14                                                               Obreli-Neto *et al*, 2012[@R28]\   Y                                     Y                       Y                                Y   Y                                                                                                                                                Y             Y   Y (4 months)                       Incidence of DDI-related ADR (6.9%)                                                                                                                         95% CI, p\<0.05                               Y   Y                                N   Recall bias from weekly meeting with patient.\                                                                                                                                                                        Moderate
                                                                   DDI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Most instruments available for assessing DDIs consider only pairs of drugs and do not account for interaction involving combinations of three or more drugs so the risk of DDI may be underestimated.                 

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  15                                                               Blozik *et al*, 2013[@R62]\        Y                                     Y                       Y                                Y   Y, gender                                                                                                                                        Y             Y   Y (3 years)                        Prevalence of PIM: 21.1%                                                                                                                                    95% CI                                        Y   Y                                Y   --                                                                                                                                                                                                                    High
                                                                   Adult                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Age, number of medications, number of disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  16                                                               Cahir *et al*, 2014[@R63]\         Y                                     Y                       Y                                Y   Y, age, gender, socioeconomic status, private health insurance, comorbidity, number of repeat drug, social support and network, adherence        Y             Y   Y (6 months) retrospective study   Prevalence of potentially IP was 40.5%.                                                                                                                     95% CI                                        Y   N                                Y   Recall bias due to self-reported ADE                                                                                                                                                                                  Moderate
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  17                                                               Zimmermann\                        Y                                     Y                       Y                                Y   Y, gender age, number of medications, number of disease, depression, education                                                                   Y             Y   Y (4.5 years)                      At baseline PIM prevalence is 29% (848) according to the PRISCUS list,\                                                                                     95% CI, p\<0.05, OR and CI for risk factors   Y   Y                                Y   --                                                                                                                                                                                                                    High
                                                                   *et al*, 2013[@R18]\                                                                                                                                                                                                                                                                                                                        which decreased\                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 to 25.0% (464) 4.5 years later and 21% according to the Beers list decreasing after 4.5 years to 17.1% (317).                                                                                                                                                                                                                                                                                                                                                            

  None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  18                                                               Amos *et al*, 2015[@R67]\          Y                                     Y                       Y                                Y   Y, age, gender, geographical location, number of medication                                                                                      Y             Y   Y (1 year) retrospective study     PIM prevalence 28%, and older age, female, number of medications increase risk of PIM                                                                       95% CI, p\<0.05                               Y   Cannot tell                      Y   May underestimate the true PIM prevalence because they do not account for OTC.                                                                                                                                        Moderate
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Number of chronic conditions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  19                                                               Hedna *et al*, 2015[@R68]\         Y                                     Y                       Y                                Y   N                                                                                                                                                Y             Y   Y (3 months) retrospective         Potentially IP prevalence: 42%\                                                                                                                             95% CI, p\<0.05                               Y   Cannot tell                      Y   Undetected confounders                                                                                                                                                                                                Moderate
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 ADR caused by potentially IP.                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Age, gender, number of medication, number of chronic condition                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  20                                                               Moriarty *et al*, 2015[@R69]\      Y                                     Y                       Y                                Y   Y, age, gender, number of medication, number of chronic condition, level of education                                                            Y             Y   Y (1 year)                         PIM prevalence: 36.7%--64.8%.\                                                                                                                              95% CI                                        Y   Y                                Y   Lack of information on OTC from the pharmacy claim data.                                                                                                                                                              High
                                                                   Elderly-PIM                                                                                                                                                                                                                                                                                                                                 Female, age and higher number of medicines were associated with change in PIM prevalence.\                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                               Age and higher numbers of medicines and chronic conditions were found to be associated with change in PPO prevalence.                                                                                                                                                                                                                                                                                                                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1 Did the study address a clearly focused issue?

2 Was the cohort recruited in an acceptable way?

3 Was the exposure accurately measured to minimise bias?

4 Was the outcome accurately measured to minimise bias?

5(a) Have the authors identified all important confounding factors? List the ones you think might be important, that the author missed.

5(b) Have they taken account of the confounding factors in the design and/or analysis?

6(a) Was the follow-up of subjects complete enough?

6(b) Was the follow-up of subjects long enough?

7 What are the results of this study?

8 How precise are the results?

9 Do you believe the results?

10 Can the results be applied to the local population?

11 Do the results of this study fit with other available evidence?

12 What are the implications of this study for practice?

ADE, adverse drug event; ADR, adverse drug reaction; ATC, Anatomical Therapeutic Chemical; DDI, drug--drug interaction; ED, emergency department; IP, inappropriate prescribing; IPET, improved prescribing in the elderly tool; N, no; OTC, over-the-counter; PIM, potentially inappropriate medication; PPO, potential prescribing omission, U, unclear;Y, yes.

Nine studies were conducted in Asia, 4 in Australia, 32 in Europe, 8 in North America, 5 in South America and 2 were conducted across continents (one study covering two Australian countries, three European countries, one North American country and one South American country,[@R20] and one study across two Australian countries, four European countries, one North American country and one South American country).[@R21] Nineteen studies were conducted in primary healthcare or general practice contexts, 15 studies in home or community settings, 16 studies in ambulatory care or outpatient settings, 5 studies in community pharmacies and 2 studies in postdischarge settings, while 3 studies used secondary data analysis.

Eleven studies enrolled adults in all age groups (\>18 years), three studies reported the mean age only,[@R22] one enrolled those 55 years or older,[@R25] five enrolled those aged 60 years or older,[@R26] and the majority of studies (n=40 studies, 67%) enrolled patients 65 years or older. If the study included adult and paediatric data, only relevant adult data were extracted.

The quality of the cross-sectional or descriptive studies using the JBI Critical Appraisal Checklist was high for nine studies, moderate for ten studies and low for one study. The quality of the cohort studies using the CASP quality assessment tool was high for 37 studies and moderate for 3 studies.

Different methods of medication errors and error-related adverse events identification were used in the studies, including data review (electronic/paper-based medical record review, lab review, prescription review), database analysis, patient survey (face-to-face or telephone interview and survey or questionnaire), patient self-report and home visits.

Medication errors {#s4}
=================

Incidence and/or prevalence {#s4a}
---------------------------

We found no study reporting data on the incidence of medication errors. Estimates of community setting medication error prevalence were available from 53 studies.[@R18]

### Self-reported medication errors {#s4a1}

The period prevalence of self-reported medication errors was measured in four cross-sectional studies by Adams *et al*, Lu and Roughead, Sears *et al* [@R21] and Mira *et al*.[@R20] In the first three studies, the period prevalence was reported as 2%, 6% and 6%, respectively,[@R20] while in Mira *et al*'s study 75% of elderly patients with multiple comorbidities and polypharmacy (five or more drugs) reported having made at least one mistake with their medication (including errors related to dose, similar appearance of medications and lack of understanding of the physician's instructions).[@R73] In this study, in 5% of cases, errors due to drug confusion had very severe consequences, requiring a visit to the emergency services or hospital admission.[@R73] That wide differences in prevalence were seen between the first three studies and the last may be due to population factors. Mira *et al*'s study population comprised older polymedicated patients with multiple comorbidities. This elderly group had a greater risk of error, while the first three studies had populations including any patient over 18 years.

Medication error according to medicines' management process {#s5}
===========================================================

Prescribing errors {#s5a}
------------------

The point or period prevalence of prescribing errors was reported in 46 studies. In these studies, prescribing errors included errors in drug indications, drug--disease interactions, drug--drug interactions (DDI) and dosing error, as well as inappropriate prescribing, which was the most common error reported.

### Indication {#s5a1}

Koper *et al* [@R23] found that, on average, 2.7 medications per patient were not indicated, with a total of 94% of patients having medications prescribed by the general practitioner (GP), but not mentioned in the indication of the UpToDate.[@R23]

### Drug--disease interactions or contraindications {#s5a2}

Drug--disease interactions were measured in one study by Mand *et al* [@R33] with a prevalence of 10%.[@R33]

### Drug--drug interactions {#s5a3}

The prevalence of DDIs was measured in 11 studies and ranged from 2% to 58%.[@R23] This could in part have been due to the fact that different DDI screening tools were used, namely DDI compendia and ePocrates RX, Thomson Micromedex program, Pharmavista database, BotPlus program of the General Council of Pharmacists' Official Colleges, British National Formulary 2010, Italian computerised interaction database, DrugDigest, Drugs, Micromedex and Medscape.

### Inappropriate prescribing {#s5a4}

A.  The prevalence of potentially inappropriate medication (PIM) was measured in 37 studies in the elderly age group only (≥65 years) and ranged from 5% to 94%.[@R18] This extremely wide range of inappropriate prescribing prevalence estimates is likely to be, at least in part, due to the different detection tools used, namely Beers 2003, the 2006 Health Plan Employer Data and Information Set, improved prescribing in the elderly tool, Medication Appropriate Index, PRISCUS and Screening Tool of Older Person's Prescriptions criteria. Johnell and Fastbom[@R46] and Haider *et al* mentioned two other specific criteria.[@R46]

B.  The prevalence of potential prescribing omission (PPO) was measured in five studies for the elderly age group only (≥65 years), ranging from 23% to 57%.[@R19] PPO was detected by the Screening Tool to Alert doctors to Right Treatment and Assessing Care of Vulnerable Elders.

### Dosing errors {#s5a5}

Koper *et al* [@R23] found that overdosing and/or underdosing was found in 44% of patients.[@R23]

Monitoring errors {#s5b}
-----------------

Monitoring errors were measured in one study by Ramia and Zeenny,[@R71] who found that 73% of patients had incomplete therapeutic/safety laboratory-test monitoring tests.[@R71]

Other errors: discrepancy {#s5c}
-------------------------

One study found that at least one discrepancy between the medication lists from the pharmacy, the GP or the patient was present in 86.7% of patients.[@R31] In another study, almost half of the patients (47.6%; 95% CI 40.5 to 54.7) had one or more discrepancies in medication information at discharge.[@R32]

The reported point or period prevalence of medication errors in the community settings, including self-reported medication errors, prescribing errors (indication, drug--disease interaction, DDI, dosing error and inappropriate prescribing), monitoring error and discrepancies, had a very wide range from 2% to 94%. [Figure 2](#F2){ref-type="fig"} shows the medication errors prevalence estimates stratified according to the settings. The highest prevalence was in primary healthcare or general practice (94%).

![Medication errors prevalence estimates according to settings.](bmjopen-2017-019101f02){#F2}

Risk factors {#s6}
============

Risk factors for medication errors were either related to patients, healthcare professionals and/or medications.

Patient-related risk factors {#s6a}
----------------------------

Patient-related risk factors for the development of medication errors were discussed in 33 studies.[@R18]

Seven risk factors related to patients were addressed in the included studies: polypharmacy, increased age, number of diseases or comorbidities, female, low level of education, hospital admission and middle family income ([table 3](#T3){ref-type="table"}).

###### 

Medication errors patient-related risk factors

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Risk factor                                                                                        Studies with positive association (n)                                                 Controlled studies (n)                               Controlled for                                                                       Specific information                      OR or RR (95% or 99% CI) p values
  -------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ---------------------------------------------------- ------------------------------------------------------------------------------------ ----------------------------------------- --------------------------------------------------
  Age ≥75 years                                                                                      13 (24, 33, 37, 42, 44, 52,\                                                          10                                                   NA                                                                                   ≥80 years                                 OR 1.021 (95% CI 1.018 to 1.023) p\<0.001[@R49]
                                                                                                     53, 55, 61, 69--71, 73)                                                                                                                                                                                                                                                   

  Adjusted for age, sex, number of regular medicine and diagnosed chronic condition                  Older age                                                                             OR 1.03 (95% CI 1.02 to 1.04) p\<0.05[@R69]                                                                                                                                         

  NA                                                                                                 Older age                                                                             OR 1.05 (95% CI 1 to 1.09) p=0.046[@R57]                                                                                                                                            

  NA                                                                                                 Older age                                                                             OR 1.06 (95% CI 1.0 to 1.13) p=0.037[@R18]                                                                                                                                          

  NA                                                                                                 ≥75 years                                                                             OR 1.10 (95% CI 1.05 to 1.15) p\<0.001[@R33]                                                                                                                                        

  NA                                                                                                 ≥85 years                                                                             OR 1.18 (95% CI 1.16 to 1.20) p\<0.05[@R40]                                                                                                                                         

  Adjusted for sex, age and number of chronic drugs                                                  ≥85 years                                                                             OR 1.52 (95% CI 1.46 to 1.6)[@R38]                                                                                                                                                  

  NA                                                                                                 ≥85 years                                                                             OR 1.53 (95% CI 1.5 to 1.55) p\<0.01[@R67]                                                                                                                                          

  NA                                                                                                 ≥85 years                                                                             OR 1.79 (95% CI 1.19 to 2.83) p=0.009[@R66]                                                                                                                                         

  Adjusted for sex and age                                                                           ≥75 years                                                                             OR 4.03 (95% CI 3.79 to 4.28) p\<0.001[@R27]                                                                                                                                        

  Comorbidity or number of disease or\                                                               10 (24, 26, 33, 44, 47, 56, 59, 73, 77, 78)                                           3                                                    Adjusted for age, sex, number of regular medicines and diagnosed chronic condition   Higher number of chronic conditions       PPO: OR 1.47 (95% CI 1.39 to 1.56) p\<0.05[@R69]
  chronic condition drug group (CCDG) score ≥4                                                                                                                                                                                                                                                                                                                                 

  NA                                                                                                 CCDG score ≥4                                                                         OR 1.76 (95% CI 1.72 to 1.81) p\<0.05[@R40]                                                                                                                                         

  Adjusted for age and sex                                                                           Diagnosed disease ≥3                                                                  OR 6.43 (95% CI 3.25 to 12.44) p\<0.001[@R27]                                                                                                                                       

  CCI                                                                                                3 (52, 55, 69)                                                                        1                                                    NA                                                                                   CCI \<2                                   RR 2.885 (95% CI 1.972 to 4.22) p=0[@R65]

  Female gender                                                                                      10 (33, 35, 47, 52, 53, 62, 64, 66, 71, 73)                                           4                                                    Adjusted for age, sex, number of regular medicines and diagnosed chronic condition                                             PIM: OR 1.27 (95% CI 1.07 to 1.5) p\<0.05[@R69]

  Adjusted                                                                                                                                                                                 OR 1.6 (99% CI 1.58 to 1.64)[@R60]                                                                                                                                                  

  Adjusted for age, sex, education level, partnership, per capita income and occupation                                                                                                    Beers 2003: OR 2.5 (95% CI 1.9 to 3.5)\                                                                                                                                             
                                                                                                                                                                                           Beers 2012: OR 1.8 (95% CI 1.3 to 2.5)[@R29]                                                                                                                                        

  Adjusted for sex and age                                                                                                                                                                 OR 2.49 (95% CI 2.29 to 2.75) p\<0.001[@R27]                                                                                                                                        

  Health literacy or low education                                                                   2 (52, 79)                                                                            1                                                    Adjusted for age, sex, type of residential area and comorbidity                                                                OR 1.09 (95% CI 1.07 to 1.17)[@R48]

  Hospital admission                                                                                 2 (26, 56)                                                                            1                                                    NA                                                                                                                             OR 3.35 (95% CI 2.43 to 4.62) p\<0.05[@R52]

  Middle family income                                                                               1 (62)                                                                                NA                                                   NA                                                                                                                             

  Polypharmacy                                                                                       26 (22--24, 33, 35--37, 41, 42, 44--46, 53, 55--57, 59, 61, 62, 68--71, 73, 74, 78)   18                                                   NA                                                                                   Higher number of prescribed medications   OR 1.06 (95% CI 1.39 to 1.98) p\<0.001[@R57]

  Adjusted for age, sex, number of regular medicines and diagnosed chronic condition                 Higher number of prescribed medications                                               PIM: OR 1.2 (95% CI 1.17 to 1.24) p\<0.05\                                                                                                                                          
                                                                                                                                                                                           PPO: OR 1.04 (95% CI 1.01 to 1.07) p\<0.05[@R69]                                                                                                                                    

  NA                                                                                                 ≥4 medications                                                                        OR 1.91 (95% CI 1.83 to 2.0) p\<0.001[@R33]                                                                                                                                         

  NA                                                                                                 Higher number of prescribed medications                                               OR 1.99 (95% CI 1.80 to 2.18) p=0.000[@R18]                                                                                                                                         

  Adjusted for age, sex, education level, partnership, per capita income and occupation              ≥5 medications                                                                        Beers 2003: OR 2.9 (95% CI 2.1 to 3.8)\                                                                                                                                             
                                                                                                                                                                                           Beers 2012: OR 2.7 (95% CI 2 to 3.6)[@R29]                                                                                                                                          

  Adjusted for disability, coronary artery disease, heart failure and other comorbidities            ≥5 medications                                                                        IP: OR 2.9 (95% CI 1.5 to 5.8)\                                                                                                                                                     
                                                                                                                                                                                           Potential major DDI: 3.8 (95% CI 1.7 to 8.2)[@R37]                                                                                                                                  

  Adjusted for age, sex, number of chronic conditions and number or drug consumed                    ≥3 medications                                                                        OR 3.21 (95% CI 2.78 to 3.59) p\<0.001[@R27]                                                                                                                                        

  Adjusted for age, sex, length of hospital stay and residential situation                           ≥5 medications                                                                        OR 3.22 (95% CI 1.40 to 7.42) p=0.006[@R32]                                                                                                                                         

  NA                                                                                                 ≥6 medications                                                                        OR 3.37 (95% CI 2.08 to 5.48) p\<0.001[@R30]                                                                                                                                        

  NA                                                                                                 ≥7 medications                                                                        OR 4.528 (95% CI 4.52 to 4.54) p\<0.001[@R49]                                                                                                                                       

  Adjusted for age, sex, CCI, history of cardiovascular disorder and history of digestive disorder   ≥5 medications                                                                        OR 5.4 (95% CI 3 to 9.7) p\<0.001[@R64]                                                                                                                                             

  Adjusted for sex, age and number of chronic drugs                                                  ≥6 medications                                                                        OR 5.59 (95% CI 5.39 to 5.80)[@R38]                                                                                                                                                 

  NA                                                                                                 ≥5 medications                                                                        OR 5.69 (95% CI 5.0 to 6.48) p\<0.05[@R52]                                                                                                                                          

  NA                                                                                                 ≥6 medications                                                                        STOPP: RR 6.837 (95% CI 4.155 to 11.247)\                                                                                                                                           
                                                                                                                                                                                           START: RR 2.051 (95% CI 1.25 to 3.367)[@R65]                                                                                                                                        

  NA                                                                                                 ≥10 medications                                                                       OR 7.33 (95% CI 7.15 to 7.51) p\<0.05[@R40]                                                                                                                                         

  NA                                                                                                 ≥9 medications                                                                        OR 7.43 (95% CI 3.20 to 17.23) p\<0.001[@R66]                                                                                                                                       

  NA                                                                                                 ≥10 medications                                                                       Male: OR 8.2 (95% CI 8 to 8.4)\                                                                                                                                                     
                                                                                                                                                                                           Female: OR 9.6 (95% CI 8.2 to 11.2)[@R42]                                                                                                                                           

  NA                                                                                                 ≥10 medications                                                                       OR 11.45 (95% CI 11.2 to 11.7) p\<0.01[@R67]                                                                                                                                        
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Several definitions of polypharmacy existed, ranging from prescription of at least three to six medications concurrently. Twenty-six studies showed a positive association between medication error and polypharmacy,[@R18] of which 18 mentioned the estimated OR ranging from 1.06 to 11.45.[@R18]

Older age (≥75 years) was associated with medication errors in 13 studies,[@R18] of which 10 mentioned the OR ranging from 1.02 to 4.03.[@R18]

Healthcare professional-related risk factors {#s6b}
--------------------------------------------

Nine risk factors related to healthcare professionals for the development of medication errors were identified: more than one physician involved in their care, family medicine/GP specialty, age ≥51 years, male GP, frequent changes in prescription, not considering the prescription of other physicians, inconsistency in the information and outpatient clinic visits (see [table 4](#T4){ref-type="table"}).[@R27]

###### 

Medication errors healthcare professional-related risk factors

  Risk factor                                                                       Studies with positive association (n)             Controlled studies (n)   Adjusted for   OR or RR or beta (95% or 99% CI) p values
  --------------------------------------------------------------------------------- ------------------------------------------------- ------------------------ -------------- ---------------------------------------------------------------
  Age ≥51 years                                                                     2 (53, 71)                                        2                        NA             OR 1.03 (95% CI 1.01 to 1.06) p\<0.01[@R67]
  NA                                                                                OR 1.238 (95% CI 1.235 to 1.242) p\<0.001[@R49]                                           
  More than one physician involved in their care                                    5 (22, 33, 64, 77, 78)                            3                        NA             Beta 0.7 (95% CI 0.5 to 1.0) p=0.034[@R73]
  Adjusted for age, sex, number of chronic conditions and number or drug consumed   OR 1.39 (95% CI 1.17 to 1.67) p\<0.001[@R27]                                              
  Adjusted for age and number of prescriber                                         OR 3.52 (99% CI 3.44 to 3.60)[@R60]                                                       
  Male general practitioner                                                         2 (53, 71)                                        2                        NA             OR 1.07 (95% CI 1.05 to 1.10) p\<0.01[@R67]
  NA                                                                                OR 1.206 (95% CI 1.202 to 1.210) p\<0.001[@R49]                                           
  Frequent changes in prescription                                                  1 (77)                                            1                        NA             Beta 0.4 (95% CI 0.2 to 0.9) p=0.019[@R73]
  Not considering the prescription of other physicians                              1 (77)                                            1                        NA             Beta 1.9 (95% CI 1.1 to 3.2) p=0.013[@R73]
  Inconsistency in the information                                                  1 (77)                                            1                        NA             Beta 4.4 (95% CI 1.3 to 14.8) p=0.013[@R73]
  Outpatient clinic visit                                                           1 (46)                                            1                        NA             1.4 (male 95% CI 1.3 to 1.4) (female 95% CI 1.3 to 1.6)[@R42]
  Family medicine/general practice specialty                                        3 (53, 56, 71)                                    3                        NA             OR 1.06 (95% CI 1.03 to 1.10) p\<0.01[@R67]
  NA                                                                                OR 1.267 (95% CI 1.265 to 1.269) p\<0.001[@R49]                                           
  NA                                                                                OR 1.46 (95% CI 1.28 to 1.65) p\<0.05[@R52]                                               

CCI, Charlson Comorbidity Index; IP, inappropriate prescribing; NA, not applicable; PIM, potentially inappropriate medication; PPO, potential prescribing omission; START, Screening Tool to Alert doctors to Right Treatment; STOPP, Screening Tool of Older Person's Prescriptions.

Medication-related risk factors {#s6c}
-------------------------------

Medication-related risk factors for the development of medication error were multiple medication storage locations used, expired medication present, discontinued medication repeats retained, hoarding of medications, therapeutic duplication,[@R25] no medication administration routine, poor adherence and patients confused by generic and trade names.[@R76] In one study by Johnell and Fastbom,[@R46] multidose drug dispensing users (ie, medicines machine-packed into unit-dose bags for each time of administration) were more exposed to all indicators of potentially inappropriate drug.[@R46]

Receiving anticoagulant therapy (OR 2.38, 95% CI 2.15 to 2.64) was strongly associated in one study to potential drug--disease interactions.[@R33]

The use of OTC and/or prescribed drugs was a risk factor in two additional studies.[@R29] The use of OTC medications was associated with PIM; the OR after adjusting for age, sex, education level, partnership, per capita income and occupation was 2.5 (95% CI 1.7 to 3.6) using Beers 2003 and 1.8 (95% CI 1.2 to 2.5) using Beers 2012.[@R29]

Error-related adverse events {#s7}
============================

Error-related adverse events or preventable ADEs were mentioned in six studies.[@R22] The most frequently reported consequences were ED visits and hospitalisation.

Two methods for detecting ADE were applied: an ADE monitor (ie, using computerised programs composed of rules that identified incidents suggesting that an ADE might be present)[@R22] and using trigger tools to detect ADEs.[@R77]

Incidence and/or prevalence {#s7a}
---------------------------

One study estimated preventable ADE incidence as 15/1000 person-years.[@R22] ACE inhibitors and beta-blockers were the most common medications associated with preventable ADE.[@R22] The estimate of the prevalence of preventable ADE was calculated from five studies as detailed below.[@R28]

### All stages of medicines' management process {#s7a1}

Field *et al* found the prevalence of error caused by patients leading to an adverse event to be 0.38%, that is, less than 1% of the overall population experienced a medication-related adverse event. They found that the majority of patient errors-related adverse events (n=129) occurred in modifying the medication regimen (42%), administering the medication (32%) or not following clinical advice about medication use (22%).[@R77] The medications associated with more than 10 preventable ADEs were anticoagulants/antiplatelets, cardiovascular drugs, diuretics, hypoglycaemics and non-opioid analgesics.[@R77]

Error-related adverse events according to medicines' management process {#s8}
=======================================================================

Prescribing errors {#s8a}
------------------

### Drug--drug interaction {#s8a1}

Obreli-Neto *et al* [@R28] found that DDI-related adverse drug reaction (ADR) occurred in 7% of patients. Warfarin, digoxin, spironolactone and acetylsalicylic acid were the drugs most commonly associated with DDI-related ADRs.[@R28]

### Potentially inappropriate medication {#s8a2}

Forty-six per cent of participants reported complaints related to ADEs by interview; 95% of these were caused by prescribed medications.[@R29]

Use of inappropriate drugs was associated with an increased risk of nursing home admission, hospitalisation, more outpatient visit days, ED visits and having ADEs or ADRs.[@R44]

Other errors {#s8b}
------------

Adverse events (undertreatment due to deletions, ADR due to additions and DDI) related to discrepancy between the medication lists from the patient, the GP or the pharmacy were identified in 24% of patients.[@R31] Two discrepancies were categorised as having the potential to cause severe patient harm.[@R32]

Risk factors {#s9}
============

Risk factors for the error-related adverse events were discussed in three studies only.[@R28]

Patient-related risk factors {#s9a}
----------------------------

Field *et al* found that the number of regularly scheduled medications (seven or more medications) (OR 3.3, 95% CI 1.5 to 7.0) and a Charlson Comorbidity Index (CCI) score of 5 or more (OR 15.0, 95% CI 6.5 to 34.5) were both associated with higher risk of patient error leading to preventable ADE.[@R77] Obreli-Neto *et al* [@R28] found that an age of 80 years or more (OR 4.4, 95 % CI 3.0 to 6.1, p\<0.01), a CCI of 4 or more (OR 1.3, 95% CI 1.1 to 1.8, p\<0.01) and consumption of five or more medications (OR 2.7, 95% CI 1.9 to 3.1, p\<0.01) were associated with the occurrence of DDI-related ADRs. In addition, Tulner *et al* [@R31] found that the number of medications was significantly positively correlated with medication discrepancy adverse patient events.

Medication-related risk factors {#s9b}
-------------------------------

The use of medication with narrow therapeutic indices such as warfarin was associated with an increased risk of DDI-related ADRs (OR 1.7, 95% CI 1.1 to 1.9, p\<0.01).[@R28]

Discussion {#s10}
==========

Summary of main findings {#s10a}
------------------------

We sought to critically review previous studies conducted in the community of the incidence/prevalence of medication errors and associated adverse events and to identify the main risk factors. We identified 60 studies carried out in various countries providing a comprehensive assessment of the available evidence on the epidemiology of medication errors and error-related ADEs in community settings.

No relevant studies on the incidence of medication errors in these settings were found. The reported point or period prevalence of medication errors in community settings had a very wide range (ie, 2%--94%). This wide range appears, at least in part, to be due to the inconsistency in the definitions of the medication errors used in the studies, differences in populations studied, methodologies employed for error detection and different outcome measures. More than half (37 studies) of the resulting studies were regarding the prescription of inappropriate drugs within the prescribing error stage in an elderly age group using different criteria. The comparison of those criteria is challenging due to the difference in medication use, consumption and availability of those medications to patients between countries. Further work is needed to review errors occurring at administration and dispensing stages of the medicines' management process.

As for preventable ADEs, which may in some cases occur as a result of medication errors, only one study reported error-related adverse events incidence, measured as 15/1000 person-years.[@R22] The prevalence of preventable ADE was further reported in five other studies and varied according to the medication error type that resulted in the adverse event.

The most common patient-related risk factors for both medication errors and preventable ADEs mentioned were the number of medications used by the patient and the increased age of patients.

Strengths and limitations {#s10b}
-------------------------

The main strength of this systematic review is that a rigorous and transparent process has been employed, which included no language restrictions, an independent screening of titles and abstracts, independent data extraction and critical appraisal of included studies by two reviewers. It is the first review undertaken within community settings. The use of the ICPS conceptual framework,[@R17] which provides a comprehensive definition of each concept and type of error in the medicines' management process, is a further strength.

However, several limitations need to be considered. First, despite the thorough process, no data were found regarding the dispensing error stage. This might be due to the lack of a 'dispensing error' key term in our search strategy, although 'medication therapy management' as a key term was included. However, 10 studies on dispensing errors were excluded because they failed to satisfy the inclusion criteria on one or more counts. Second, no data were found regarding the administration error stage. However, 14 studies on administration errors were also excluded for the same previous reason. Third, this systematic review had different outcomes reported in a variety of ways using different tools and methodology, which made combining results in one meta-analysis difficult. Lastly, the studies addressed risk factors adjusted for different confounders, which makes it difficult to generate comparable estimates and/or make causal inferences about whether the harm resulted from the medication error.

Comparison of the findings with previous studies {#s10c}
------------------------------------------------

The definitional variation issue is supported by another two reviews.[@R78] Other systematic reviews focusing on the safety of primary care contexts only have identified studies with vastly different prevalence estimates of the rates of medication errors. These reflect differences in definitions, sampling strategy and populations studied; none have investigated the risk factors for medication errors.[@R80]

Implications for research, policy and practice {#s10d}
----------------------------------------------

There is a need for (1) improvement in the quality of research in this area---it is important that all researchers provide a standardised set of outcome measures of medication errors or internationally accepted terminology and definitions of key concepts; (2) training and monitoring of healthcare professionals with the involvement of medication safety pharmacists in the community; (3) empowering and educating the patients and the public, particularly those with chronic diseases and polypharmacy, to increase their knowledge of medication safety with a record of the current medication list for each patient; (4) patient use of tools and technology particularly for monitoring and follow-up; and (5) encourage the reporting of medication errors, administration errors and dispensing errors.[@R82] This would strengthen the quality of research, improve the development of strategies to detect and prevent these errors, and provide a safer environment for the community to self-care safely.

Conclusions {#s11}
===========

We found a very wide variation in the medication error and error-related adverse events rate between studies, which, at least in part, reflects differences in their definitions, methodologies employed for error detection or clinical heterogeneity, that is, differences in populations studied and different outcome measures. Most of the studies were conducted on elderly populations in economically developed countries. There is therefore clearly a need to extend this work to low-income and middle-income countries, particularly give the WHO's recent launch of a Global Medication Safety Challenge.[@R82] Furthermore, most studies focused only on inappropriate prescribing with relatively little attention to other stages such as administration and dispensing. The most common patient and medication-related risk factors for both medication errors and preventable ADEs were the number of medications used by the patient, increased age and receiving anticoagulant therapy. The most common healthcare professional-related risk factor for medication error was when more than one practitioner was involved in the care of patients and care provision by family medicine and GP specialities.

This study has identified important limitations and discrepancies in the methodology used to study medication errors and error-related ADEs in community settings. These findings need to be considered in the context of designing future research related to medication safety. More research is needed in the areas of incidence of medication errors, administration error and dispensing errors and reporting. Researchers should use a more consistent set of definitions and outcomes in order to facilitate collation and synthesis of data.

Ethics and dissemination {#s12}
========================

The systematic review protocol was published in *BMJ Open* on 31 August 2016 and is registered with PROSPERO, an international prospective register of systematic reviews.[@R11] It is reported using PRISMA. Trial registration number: CRD42016048126.
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